0001471781 2026-01-01 2026-03-31 0001471781 2026-05-13 0001471781 2026-03-31 0001471781 2025-12-31 0001471781 us-gaap:SeriesBPreferredStockMember 2026-03-31 0001471781 us-gaap:SeriesBPreferredStockMember 2025-12-31 0001471781 us-gaap:SeriesCPreferredStockMember 2026-03-31 0001471781 us-gaap:SeriesCPreferredStockMember 2025-12-31 0001471781 us-gaap:SeriesDPreferredStockMember 2026-03-31 0001471781 us-gaap:SeriesDPreferredStockMember 2025-12-31 0001471781 us-gaap:SeriesGPreferredStockMember 2026-03-31 0001471781 us-gaap:SeriesGPreferredStockMember 2025-12-31 0001471781 us-gaap:SeriesHPreferredStockMember 2026-03-31 0001471781 us-gaap:SeriesHPreferredStockMember 2025-12-31 0001471781 GTCH:SeriesIPreferredStockMember 2026-03-31 0001471781 GTCH:SeriesIPreferredStockMember 2025-12-31 0001471781 2025-01-01 2025-03-31 0001471781 us-gaap:SeriesBPreferredStockMember 2024-12-31 0001471781 us-gaap:SeriesCPreferredStockMember 2024-12-31 0001471781 us-gaap:SeriesHPreferredStockMember 2024-12-31 0001471781 GTCH:SeriesIPreferredStockMember 2024-12-31 0001471781 us-gaap:CommonStockMember 2024-12-31 0001471781 us-gaap:TreasuryStockCommonMember 2024-12-31 0001471781 GTCH:ShareToBeCancelledMember 2024-12-31 0001471781 GTCH:StockLoanReceivableMember 2024-12-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001471781 us-gaap:RetainedEarningsMember 2024-12-31 0001471781 us-gaap:NoncontrollingInterestMember 2024-12-31 0001471781 2024-12-31 0001471781 us-gaap:CommonStockMember 2025-12-31 0001471781 us-gaap:TreasuryStockCommonMember 2025-12-31 0001471781 GTCH:ShareToBeCancelledMember 2025-12-31 0001471781 GTCH:StockLoanReceivableMember 2025-12-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001471781 us-gaap:RetainedEarningsMember 2025-12-31 0001471781 us-gaap:NoncontrollingInterestMember 2025-12-31 0001471781 us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-03-31 0001471781 us-gaap:SeriesCPreferredStockMember 2025-01-01 2025-03-31 0001471781 us-gaap:SeriesHPreferredStockMember 2025-01-01 2025-03-31 0001471781 GTCH:SeriesIPreferredStockMember 2025-01-01 2025-03-31 0001471781 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001471781 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0001471781 GTCH:ShareToBeCancelledMember 2025-01-01 2025-03-31 0001471781 GTCH:StockLoanReceivableMember 2025-01-01 2025-03-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001471781 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001471781 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001471781 us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001471781 us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-03-31 0001471781 us-gaap:SeriesHPreferredStockMember 2026-01-01 2026-03-31 0001471781 GTCH:SeriesIPreferredStockMember 2026-01-01 2026-03-31 0001471781 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001471781 us-gaap:TreasuryStockCommonMember 2026-01-01 2026-03-31 0001471781 GTCH:ShareToBeCancelledMember 2026-01-01 2026-03-31 0001471781 GTCH:StockLoanReceivableMember 2026-01-01 2026-03-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001471781 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001471781 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-03-31 0001471781 us-gaap:SeriesBPreferredStockMember 2025-03-31 0001471781 us-gaap:SeriesCPreferredStockMember 2025-03-31 0001471781 us-gaap:SeriesHPreferredStockMember 2025-03-31 0001471781 GTCH:SeriesIPreferredStockMember 2025-03-31 0001471781 us-gaap:CommonStockMember 2025-03-31 0001471781 us-gaap:TreasuryStockCommonMember 2025-03-31 0001471781 GTCH:ShareToBeCancelledMember 2025-03-31 0001471781 GTCH:StockLoanReceivableMember 2025-03-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001471781 us-gaap:RetainedEarningsMember 2025-03-31 0001471781 us-gaap:NoncontrollingInterestMember 2025-03-31 0001471781 2025-03-31 0001471781 us-gaap:CommonStockMember 2026-03-31 0001471781 us-gaap:TreasuryStockCommonMember 2026-03-31 0001471781 GTCH:ShareToBeCancelledMember 2026-03-31 0001471781 GTCH:StockLoanReceivableMember 2026-03-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001471781 us-gaap:RetainedEarningsMember 2026-03-31 0001471781 us-gaap:NoncontrollingInterestMember 2026-03-31 0001471781 GTCH:VisionWaveHoldingMember 2024-03-19 2024-03-20 0001471781 GTCH:TokenizeMember 2024-03-19 2024-03-20 0001471781 GTCH:TokenizeVWMember 2026-01-01 2026-03-31 0001471781 GTCH:GBTTokenizeCorpMember 2026-01-01 2026-03-31 0001471781 GTCH:GBTTechnologiesIncMember 2026-01-01 2026-03-31 0001471781 GTCH:GBTTokenizeCorpMember GTCH:TokenizeholdingsinVisionWaveMember 2026-01-01 2026-03-31 0001471781 GTCH:GBTTechnologiesIncMember GTCH:TokenizeholdingsinVisionWaveMember 2026-01-01 2026-03-31 0001471781 us-gaap:FairValueInputsLevel1Member 2025-12-31 0001471781 us-gaap:FairValueInputsLevel2Member 2025-12-31 0001471781 us-gaap:FairValueInputsLevel3Member 2025-12-31 0001471781 us-gaap:FairValueInputsLevel1Member 2026-03-31 0001471781 us-gaap:FairValueInputsLevel2Member 2026-03-31 0001471781 us-gaap:FairValueInputsLevel3Member 2026-03-31 0001471781 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001471781 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001471781 us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001471781 us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-03-31 0001471781 us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-03-31 0001471781 us-gaap:SeriesCPreferredStockMember 2025-01-01 2025-03-31 0001471781 us-gaap:SeriesHPreferredStockMember 2026-01-01 2026-03-31 0001471781 us-gaap:SeriesHPreferredStockMember 2025-01-01 2025-03-31 0001471781 GTCH:SeriesIPreferredStockMember 2026-01-01 2026-03-31 0001471781 GTCH:SeriesIPreferredStockMember 2025-01-01 2025-03-31 0001471781 GTCH:ConvertibleNotesMember 2026-01-01 2026-03-31 0001471781 GTCH:ConvertibleNotesMember 2025-01-01 2025-03-31 0001471781 GTCH:MetAlertIncsMember 2026-03-31 0001471781 GTCH:MetAlertIncsMember 2025-12-31 0001471781 GTCH:GBTTokenizeCorpMember 2023-04-03 0001471781 GTCH:GTXAgreementMember 2022-04-10 2022-04-12 0001471781 GTCH:GBTTokenizeMember 2022-04-10 2022-04-12 0001471781 GTCH:GTXAgreementMember 2022-01-01 2022-12-31 0001471781 GTCH:GTXAgreementMember 2022-04-12 0001471781 GTCH:GTXAgreementMember 2024-12-31 0001471781 GTCH:GBTTokenizeMetAlertMember 2022-09-29 2022-09-30 0001471781 GTCH:PromissoryNoteMember 2022-09-29 2022-09-30 0001471781 GTCH:PromissoryNoteMember 2023-12-31 0001471781 GTCH:MetAlertIncMember 2026-03-31 0001471781 GTCH:MetAlertIncMember 2025-12-31 0001471781 GTCH:GBTSharesMember 2020-03-05 2020-03-06 0001471781 2020-03-06 0001471781 GTCH:StanleyHillsLLCMember 2021-12-31 0001471781 GTCH:TokenizeAgreementMember 2021-05-28 0001471781 GTCH:TokenizeAgreementMember 2021-05-27 2021-05-28 0001471781 2020-03-31 0001471781 GTCH:TokenizeAgreementMember 2026-03-31 0001471781 GTCH:TokenizeAgreementMember 2026-01-01 2026-03-31 0001471781 GTCH:SeriesIPreferredStockMember GTCH:TokenizeAgreementMember 2026-03-31 0001471781 GTCH:SeriesIPreferredStockMember GTCH:TokenizeAgreementMember 2026-01-01 2026-03-31 0001471781 GTCH:GBTTokenizeMember 2025-12-31 0001471781 GTCH:VisionWaveMember 2024-03-19 2024-03-20 0001471781 GTCH:Igor1CorpMember 2026-03-31 0001471781 GTCH:Igor1CorpMember 2025-12-31 0001471781 GTCH:GlenEagleMember 2026-03-31 0001471781 GTCH:GlenEagleMember 2025-12-31 0001471781 GTCH:FlemingPLLCMember 2026-03-31 0001471781 GTCH:FlemingPLLCMember 2025-12-31 0001471781 GTCH:GBTTechnologiesMember us-gaap:SeriesHPreferredStockMember 2026-01-01 2026-03-31 0001471781 GTCH:GBTTechnologiesMember us-gaap:SeriesHPreferredStockMember 2026-03-31 0001471781 GTCH:GBTTechnologiesMember 2021-05-17 2021-05-19 0001471781 2021-01-01 2021-12-31 0001471781 2024-06-29 2024-07-02 0001471781 GTCH:IgorCorpMember 2026-03-31 0001471781 GTCH:IgorCorpMember 2025-12-31 0001471781 GTCH:GlenEaglesAcquisitionLPMember 2026-01-01 2026-03-31 0001471781 GTCH:GlenEaglesAcquisitionLPMember 2023-01-24 0001471781 GTCH:GlenEaglesAcquisitionLPMember 2023-01-23 2023-01-24 0001471781 GTCH:GlenEaglesAcquisitionLPMember 2024-01-01 2024-09-30 0001471781 2024-01-01 2024-12-31 0001471781 2026-02-05 0001471781 GTCH:GlenEaglesAcquisitionLPMember 2025-03-31 0001471781 GTCH:GlenEaglesAcquisitionLPMember 2025-12-31 0001471781 GTCH:FlemingPLLCMember 2026-02-05 0001471781 GTCH:FlemingPLLCMember 2026-01-31 0001471781 GTCH:FlemingPLLCMember 2025-03-31 0001471781 GTCH:FlemingPLLCMember 2025-12-31 0001471781 GTCH:SBALoanMember 2026-03-31 0001471781 GTCH:SBALoanMember 2025-12-31 0001471781 GTCH:GlenEaglePromissoryNoteMember 2026-03-31 0001471781 GTCH:GlenEaglePromissoryNoteMember 2025-12-31 0001471781 GTCH:SBALoanMember GTCH:EIDLMember 2020-06-21 2020-06-22 0001471781 GTCH:SBALoanMember 2021-10-01 0001471781 GTCH:SBALoanMember 2022-03-17 0001471781 GTCH:SBALoanMember 2021-10-04 2021-10-05 0001471781 GTCH:GlenEaglePromissoryNoteMember 2026-02-06 0001471781 GTCH:GlenEaglePromissoryNoteMember 2026-02-01 2026-02-06 0001471781 GTCH:GlenEaglePromissoryNoteMember 2026-01-01 2026-03-31 0001471781 GTCH:GlenEaglePromissoryNoteMember 2025-01-01 2025-12-31 0001471781 GTCH:GlenEaglePromissoryNoteMember 2026-03-31 0001471781 GTCH:GlenEaglePromissoryNoteMember 2025-12-31 0001471781 GTCH:StanleyHillsLLCMember 2019-05-03 2019-12-31 0001471781 GTCH:StanleyHillsLLCMember 2020-02-26 0001471781 GTCH:StanleyHillsLLCMember 2020-02-25 2020-02-26 0001471781 GTCH:StanleyHillsLLCMember 2021-01-01 2021-12-31 0001471781 us-gaap:ConvertibleDebtMember GTCH:StanleyHillsLLCMember 2021-12-31 0001471781 GTCH:StanleyHillsLLCMember 2023-01-02 0001471781 GTCH:StanleyHillsLLCMember 2023-01-01 2023-01-02 0001471781 GTCH:StanleyHillsLLCMember 2026-01-01 2026-03-31 0001471781 GTCH:StanleyHillsLLCMember 2025-01-01 2025-03-31 0001471781 GTCH:StanleyHillsLLCMember 2025-01-01 2025-03-31 0001471781 GTCH:StanleyHillsLLCMember 2026-03-31 0001471781 GTCH:StanleyHillsLLCMember 2025-12-31 0001471781 2020-11-15 0001471781 GTCH:AlphaEdaMember 2026-03-31 0001471781 GTCH:AlphaEdaMember 2025-12-31 0001471781 GTCH:AlphaEdaMember 2026-03-31 0001471781 GTCH:AlphaEdaMember 2025-12-31 0001471781 2022-07-07 0001471781 GTCH:BoardOfDirectorsMember 2026-01-01 2026-03-31 0001471781 2023-10-12 0001471781 2025-01-01 2025-12-31 0001471781 us-gaap:CommonStockMember 2026-03-31 0001471781 us-gaap:CommonStockMember 2025-12-31 0001471781 us-gaap:SeriesHPreferredStockMember GTCH:AltcorpMember 2019-06-16 2019-06-17 0001471781 us-gaap:SeriesHPreferredStockMember GTCH:AltcorpMember 2019-06-17 0001471781 GTCH:GBTMember GTCH:SeriesIPreferredStockMember 2023-07-19 2023-07-20 0001471781 GTCH:GBTMember GTCH:SeriesIPreferredStockMember 2023-07-20 0001471781 GTCH:SharesToBeCancelledMember 2026-03-31 0001471781 GTCH:SharesToBeCancelledMember 2025-12-31 0001471781 GTCH:VisionWaveHoldingsMember 2024-03-19 2024-03-20 0001471781 GTCH:TokenizeMember 2024-03-19 2024-03-20 0001471781 GTCH:TokenizeHoldingsMember 2026-01-01 2026-03-31 0001471781 GTCH:GBTTokenizeCorpMember GTCH:TokenizeholdingsinVisionWaveOneMember 2026-01-01 2026-03-31 0001471781 GTCH:GBTTechnologiesIncMember GTCH:TokenizeholdingsinVisionWaveOneMember 2026-01-01 2026-03-31 iso4217:USD shares iso4217:USD shares pure false Q1 --12-31 2026 0001471781

10-Q true 2026-03-31 false 000-54530 GBT TECHNOLOGIES INC. NV 27-0603137 117 W 9th St, Suite 1214 Los Angeles CA 90015 213 784-1640 Yes Yes Non-accelerated Filer true false false 22217870775

262

595

83637

83922

603

83922

603

749893

897008

628906 576284 1146164 1146164 2139905 2117394

240000

5150161

5170161

474599 474599 140000 140000

10669629

10521610

350000

19374

83637

453011

350000

11122640

10871610

0.00001

20000000

45000

0.00001

10000

700

0.00001

100000

0.00001

2000000

0.00001

40000

20000

0.00001

1000

0.00001

30000000000

22217870775

20217870775

222179

202179

11059

286012905

-296184220

-295996525

-9960195

-9792500

-1078523

-1078508

-11038718

-10871007

83922

603

3161

7241

7295

3161

-7295

-3161

120000

300430

97924

-15 1315

-180415

-99239

-187710

-102400

-187710 -102400

-187710

-102400

-15

-1191

-187695

-101209

21734354291

16813229180

663507515446

608088756361

-0.00

45000

700

20000

1000

16813229180

168133

-11059

1032

-632000

-7610147

294255052

-295278233

-1075865

-10184119

-101209

-1191

-102400

45000

700

20000

1000

16813229180

168133

-11059

1032

-632000

-7610147

294255052

-295379442

-1077056

-10286519

45000

700

20000

1000

20217870775

202179

-11059

1032

286012905

-295996525

-1078507

-10871007

2000000000

20000.00

20000

-187695

-15

-187711

45000

700

20000

1000

22217870775

222179

-11059

1032

286012905

-296184220

-1078522

-11038718

187710

102400

19374

-120000 -15 1316 180000

-94494

81735

202512

19368

-333

595

125

262

144

360000 -20000 83627

Note 1 - Organization and Basis of Presentation Organization and Line of Business GBT Technologies Inc. (the “Company”, “GBT”, or “GTCH”) was incorporated on July 22, 2009 under the laws of the State of Nevada. The Company is targeting growing markets such as development of Internet of Things (IoT) and Artificial Intelligence (AI) enabled networking and tracking technologies, including wireless mesh network technology platform and fixed solutions, development of an intelligent human body vitals device, asset-tracking IoT, and wireless mesh networks. On July 20, 2023, the Company through its wholly owned subsidiary, Greenwich International Holdings, a Costa Rica corporation (“Greenwich”), entered into an Amended and Restated Joint Venture (the “2023 Tokenize Agreement”) with Magic Internacional Argentina FC, S.L. (“Magic”) and GBT Tokenize Corp (“GBT Tokenize” or “Tokenize”). GBT Tokenize has developed a vital device based on the Technology Portfolio that is ready for commercialization, as well as certain derivative technologies, which positioned GBT Tokenize to further develop or license certain code sources. On April 3, 2023, GBT Tokenize entered its first commercial transaction to date through the sale of the Avant-AI! technology that been developed by GBT Tokenize, based on the Technology Portfolio. Effective as of March 20, 2024, Tokeniz, entered into a Patent Purchase Agreement with VisionWave Technologies Inc. (“VisionWave” or “VW”) pursuant to which VisionWave agreed to acquire from Tokenize the entire right, title, and interest of certain patents and patent applications providing an intellectual property basis for a machine learning driven technology that controls radio wave transmissions, analyzes their reflections data, and constructs 2D/3D images of stationary and in motion objects (“VisionWave PPA”). The Purchase Price for the asset is $30,000,000 (the “Purchase Price”), which VisionWave will pay with shares of common stock, $0.0001 par value per share (the “Common Stock”). The Parties agree that the final Purchase Price may be adjusted and will be governed by a valuation report issued by a professional third party (“Valuation”). If the final Purchase Price per Valuation is less than $30,000,000, Tokenize has the option to cancel this Agreement. In accordance therewith, VisionWave agreed to issue and deliver to Tokenize, 1,000 shares of Common Stock (the “Shares”) representing 50% of VisionWave’s issued and outstanding shares of Common Stock, where the remainder of the 50% of VisionWave’s issued and outstanding shares of Common Stock are owned by a corporation controlled by Anat Attia. On June 4, 2024 Tokenize were issued additional 222 shares of VW for consideration of ten million Avant Technologies Inc. (“AVAI”) shares. On August 17, 2024 Tokenize, the Company. and Magic entered into agreements effective March 26, 2024 which assign the shares issued by the Company to Tokenize, 500 to GBT and 500 to Magic. Post this transaction the Company holds 500 shares and Tokenize hold 222 shares of VW. As of September 30, 2025, the Company holds 26.53% of VW’s issued and outstanding shares. Here is the breakdown of the Company and Tokenize VW’s shareholders: <table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfShareholdersSharesIssuedAndOutstandingTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TokenizeVWMember_zRvxaYzQPYaf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Organization and Basis of Presentation (Details)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Shareholder’s Name</td><td> </td> <td colspan="3" style="text-align: center">No. Of Shares</td><td> </td> <td colspan="3" style="text-align: center">% of Shares Held</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">GBT Tokenize Corp.</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_ecustom--NumberOfBreakdownOfShares_c20260101__20260331__srt--CounterpartyNameAxis__custom--GBTTokenizeCorpMember_zJQLIlSurUa" style="width: 12%; text-align: right" title="Number of shares">222</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">8.16</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">GBT Technologies, Inc.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--NumberOfBreakdownOfShares_c20260101__20260331__srt--CounterpartyNameAxis__custom--GBTTechnologiesIncMember_zwOavbyitLA6" style="text-align: right" title="Number of shares">500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18.37</td><td style="text-align: left">%</td></tr> </table> On March 26, 2024, Bannix Acquisition Corp., a Delaware corporation (“Bannix”), entered into a Business Combination Agreement (the “Original Agreement”), by and among Bannix, VisionWave Technologies, Inc., a Nevada corporation (“Target”) and the shareholders of Target. On September 6, 2024, Bannix entered into a Merger Agreement and Plan of Reorganization (the “Merger Agreement”), by and among Bannix, VisionWave Holdings, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Bannix (“VisionWave Holdings”), BNIX Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of VisionWave Holdings (“Parent Merger Sub”), BNIX VW Merger Sub, Inc., a Nevada corporation and direct, wholly owned subsidiary of VisionWave, and Target. The Merger Agreement and the transactions contemplated thereby were approved by the boards of directors of each of Bannix, VisionWave Holdings, Parent Merger Sub, Company Merger Sub, and Target. Said Merger was closed on July 14, 2025 and the Company holdings in Visionwave Technologies been converted into holdings in VisionWave Holdings, Inc publicly traded on NASDAQ under the Ticker VWAV. The following is the breakdown of the Company and Tokenize holdings in VisionWave Holdings post closings: <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfShareholdersSharesIssuedAndOutstandingTableTextBlock_zEqrvYyabve4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Organization and Basis of Presentation (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Shareholder’s Name</td><td> </td> <td colspan="3" style="text-align: center">No. Of Shares</td><td> </td> <td colspan="3" style="text-align: center">% of Shares Held</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">GBT Tokenize Corp.</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_ecustom--NumberOfBreakdownOfShares_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveMember__srt--CounterpartyNameAxis__custom--GBTTokenizeCorpMember_zXnzIORbEqRg" style="width: 12%; text-align: right" title="Number of shares">897,102</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_901_ecustom--PercentageOfSharesHeld_dp_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveMember__srt--CounterpartyNameAxis__custom--GBTTokenizeCorpMember_z4XpSwi7lgO1" title="Percentage of shares held">6.286</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">GBT Technologies, Inc.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--NumberOfBreakdownOfShares_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveMember__srt--CounterpartyNameAxis__custom--GBTTechnologiesIncMember_zwFFtiOhn4t" style="text-align: right" title="Number of shares">2,020,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--PercentageOfSharesHeld_dp_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveMember__srt--CounterpartyNameAxis__custom--GBTTechnologiesIncMember_z727Vx4oYkki" title="Percentage of shares held">14.158</td><td style="text-align: left">%</td></tr> </table> The unaudited consolidated financial statements are prepared by the Company, pursuant to the rules and regulations of the SEC. The information furnished herein reflects all adjustments, consisting only of normal recurring adjustments, which in the opinion of management, are necessary to fairly state the Company’s financial position, the results of its operations, and cash flows for the periods presented. On January 9, 2026 , VisionWave Holdings, Inc. (“VWAV”) entered into a Strategic Joint Venture Agreement (the “Agreement”) with BOCA JOM, LLC (“BOCA”), GBT Tokenize Corp. (“TOKENIZE”), and GBT Technologies, Inc. (“GBT”). Pursuant to the Agreement, the parties agreed to form a joint venture limited liability company in the State of Nevada (the “JV LLC”) for the purpose of developing, commercializing, and managing designated electronic design automation (EDA), defense, and high-security technology projects (the “Designated Projects”). Certain details regarding the Designated Projects have been omitted due to their confidential and sensitive nature. This transaction represents a strategic shift in the Company’s business focus into a new line of operations involving advanced technology development and commercialization. As of the date of this report, the JV LLC is in the development and early-stage operational phase, and no revenue has been generated from the Designated Projects. JV Structure and Ownership Equity interests in the JV LLC were determined using an internal reference value of $1.0 billion solely to facilitate negotiation of ownership percentages. This internal value is not a statement of the JV’s actual fair market value and was reached without the benefit of an independent third-party valuation or fairness opinion. Accordingly, stockholders and investors are cautioned not to place undue reliance on this figure as an indication of the value of the JV, its assets, or the Company’s interest therein for securities law purposes or otherwise. Ownership of the JV LLC is expected to be allocated among the parties as set forth in the Agreement and related exhibits. Contributions <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td>TOKENIZE will contribute 897,102 shares of VWAV’s common stock and its intellectual property portfolio.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td>GBT will contribute 2,020,500 shares of VWAV’s common stock.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td>BOCA will contribute the Designated Projects.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td>BOCA and the Company will each enter into non-exclusive license agreements granting the JV LLC rights to use certain background intellectual property solely for the Designated Projects.</td></tr> </table> All contributions of VWAV securities are subject to compliance with applicable securities laws and Nasdaq Listing Rules, including obtaining shareholder approval if required under Nasdaq Rule 5635. Governance The JV LLC will be governed by a three-member board, with governance and deadlock resolution mechanisms to be set forth in a separate operating agreement. TOKENIZE and GBT will not participate in management or governance of the JV LLC. The Agreement provides that VWAV may appoint a director to BOCA’s board. Any appointment of a BOCA designee to the Company’s board would be subject to approval by the VWAV’s independent directors, compliance with Nasdaq rules, and, if applicable, shareholder approval. Intellectual Property <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td>Intellectual property developed by the JV LLC (“Foreground IP”) will be owned by the JV LLC.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td>Each party retains ownership of its independently developed intellectual property.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td>License rights terminate upon termination of the Agreement, subject to limited survival for existing customer obligations.</td></tr> </table> Termination and Regulatory Matters The Agreement has an initial term of seven years and includes customary termination rights, including termination if required regulatory approvals (such as CFIUS or export control approvals) are denied. If no Designated Project generates revenue within twelve months following formation of the JV LLC, the Agreement may be terminated and contributed consideration returned, subject to board-level fiduciary determinations. The transactions contemplated by the Agreement are subject to customary closing conditions, including receipt of regulatory approvals and execution of the JV LLC operating agreement. Basis of Presentation The accompanying condensed consolidated financial statements were prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

30000000 30000000 <table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfShareholdersSharesIssuedAndOutstandingTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TokenizeVWMember_zRvxaYzQPYaf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Organization and Basis of Presentation (Details)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Shareholder’s Name</td><td> </td> <td colspan="3" style="text-align: center">No. Of Shares</td><td> </td> <td colspan="3" style="text-align: center">% of Shares Held</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">GBT Tokenize Corp.</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_ecustom--NumberOfBreakdownOfShares_c20260101__20260331__srt--CounterpartyNameAxis__custom--GBTTokenizeCorpMember_zJQLIlSurUa" style="width: 12%; text-align: right" title="Number of shares">222</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">8.16</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">GBT Technologies, Inc.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--NumberOfBreakdownOfShares_c20260101__20260331__srt--CounterpartyNameAxis__custom--GBTTechnologiesIncMember_zwOavbyitLA6" style="text-align: right" title="Number of shares">500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18.37</td><td style="text-align: left">%</td></tr> </table> 222 0.0816 500 0.1837 <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfShareholdersSharesIssuedAndOutstandingTableTextBlock_zEqrvYyabve4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Organization and Basis of Presentation (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Shareholder’s Name</td><td> </td> <td colspan="3" style="text-align: center">No. Of Shares</td><td> </td> <td colspan="3" style="text-align: center">% of Shares Held</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">GBT Tokenize Corp.</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_ecustom--NumberOfBreakdownOfShares_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveMember__srt--CounterpartyNameAxis__custom--GBTTokenizeCorpMember_zXnzIORbEqRg" style="width: 12%; text-align: right" title="Number of shares">897,102</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_901_ecustom--PercentageOfSharesHeld_dp_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveMember__srt--CounterpartyNameAxis__custom--GBTTokenizeCorpMember_z4XpSwi7lgO1" title="Percentage of shares held">6.286</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">GBT Technologies, Inc.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--NumberOfBreakdownOfShares_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveMember__srt--CounterpartyNameAxis__custom--GBTTechnologiesIncMember_zwFFtiOhn4t" style="text-align: right" title="Number of shares">2,020,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--PercentageOfSharesHeld_dp_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveMember__srt--CounterpartyNameAxis__custom--GBTTechnologiesIncMember_z727Vx4oYkki" title="Percentage of shares held">14.158</td><td style="text-align: left">%</td></tr> </table> 897102 0.06286 2020500 0.14158

Note 2 – Going Concern The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has an accumulated deficit of $296,184,220 and has a working capital deficit of $10,585,707 as of March 31, 2026, which raises substantial doubt about its ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has plans to seek additional capital through some private placement offerings of debt and equity securities. These plans, if successful, will mitigate the factors which raise substantial doubt about the Company’s ability to continue as a going concern. These CFS do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty.

-296184220

10585707

Note 3 – Summary of Significant Accounting Policies Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying condensed consolidated financial statements include valuation of derivatives and valuation allowance on deferred tax assets. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its subsidiaries; the Company’s 50% owned subsidiary GBT Tokenize Corp. All significant intercompany transactions and balances were eliminated. Cash Equivalents For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly liquid debt instruments with original maturities of three months or less. As of March 31, 2026 and December 31, 2025, the Company did not have any cash equivalents. Marketable Securities The Company accounts for investment securities in accordance with ASC Topic 321, Investments – equity securities. Marketable equity securities are reported at FV based on quotations available on securities exchanges with any unrealized gain or loss being reported as a component of other income (expense) on the statement of operations. The portion of marketable equity security expected to be sold within 12 months of the balance sheet date is reported as a current asset. These publicly traded equity securities are valued using quoted prices and are included in Level 1. Derivative Financial Instruments The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its FV and is then re-valued at each reporting date, with changes in the FV reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a binomial option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of March 31, 2026 and December 31, 2025, the Company recorded derivative liabilities of 240,000 and 0, respectively, associated with convertible notes payable due to all the conversion features. Fair Value of Financial Instruments For certain of the Company’s financial instruments, including cash, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their FV due to their short maturities. FASB ASC Topic 820, Fair Value Measurements and Disclosures, requires disclosure of the FV of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments, defines FV, and establishes a three-level valuation hierarchy for disclosures of FV measurement that enhances disclosure requirements for FV measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. </td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>●</td> <td style="text-align: justify">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. </td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>●</td> <td style="text-align: justify">Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the FV measurement. </td></tr> </table> The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity, and FASB ASC Topic 815, Derivatives and Hedging. For certain financial instruments, the carrying amounts reported in the balance sheets for cash and current liabilities, including convertible notes payable, each qualify as a financial instrument, and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The Company uses Level 2 inputs for its valuation methodology for derivative liabilities as their FV were determined by using the Black-Scholes-Merton pricing model based on various assumptions. The Company’s derivative liabilities are adjusted to reflect FV at each period end, with any increase or decrease in the FV being recorded in results of operations as adjustments to FV of derivatives. At March 31, 2026 and December 31, 2025, the Company identified the following liabilities that are required to be presented on the balance sheet at FV: <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_znXplRi8lMjd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center">Schedule of liabilities to be presented on balance sheet at fair value </td><td> </td> <td colspan="3" style="text-align: center">Fair Value</td><td> </td> <td colspan="11" style="text-align: center">Fair Value Measurements at</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center">As of</td><td> </td> <td colspan="11" style="text-align: center">December 31, 2025</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Description</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">Using Fair Value Hierarchy</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; text-indent: -10pt; padding-left: 10pt">Conversion feature on convertible notes</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_900_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zhs1vEL6WP9e" title="Conversion feature on convertible notes">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_904_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWLoHKK9M2bk" title="Conversion feature on convertible notes">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_901_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJOF0LHXFkTj" title="Conversion feature on convertible notes">—</td><td style="width: 1%; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center">Fair Value</td><td> </td> <td colspan="11" style="text-align: center">Fair Value Measurements at</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center">As of</td><td style="color: #1D2838"> </td> <td colspan="11" style="color: #1D2838; text-align: center">March 31, 2026</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Description</td><td style="color: #1D2838; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; color: #1D2838; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">Using Fair Value Hierarchy</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; text-indent: -10pt; padding-left: 10pt">Conversion feature on convertible notes</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">240,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_90E_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zviDyPUvesz5" title="Conversion feature on convertible notes">240,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_90A_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhKdKdtFXT1j" title="Conversion feature on convertible notes">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_906_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zd7czSwdNuJd" title="Conversion feature on convertible notes">—</td><td style="width: 1%; text-align: left"> </td></tr> </table> Treasury Stock Treasury stock is recorded at cost. The re-issuance of treasury shares is accounted for on a first in, first-out basis and any difference between the cost of treasury shares and the re-issuance proceeds are charged or credited to additional paid-in capital. The Company has 8 treasury stock from acquisitions that commenced in 2011. Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented and its current on all its tax filings federal and state until 2025 inclusive. Basic and Diluted Earnings Per Share Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS assumes that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Due to the net income incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented. The following potentially-dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive. <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zSRpT7U6wBlc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">Schedule of potentially- dilutive shares</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Basic outstanding common stock</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zNqgsxVCZ6vk" style="width: 12%; text-align: right" title="Potentially-dilutive shares">22,217,870,775</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zelGxgSahCYd" style="width: 12%; text-align: right" title="Potentially-dilutive shares">20,217,870,775</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Series B preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesBPreferredStockMember_zU2jHvrBBABh" style="text-align: right" title="Potentially-dilutive shares">150,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesBPreferredStockMember_zG10AC2ywYt3" style="text-align: right" title="Potentially-dilutive shares">150,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Series C preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesCPreferredStockMember_zl9O7bjJKOCg" style="text-align: right" title="Potentially-dilutive shares">385,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesCPreferredStockMember_zv1vPv5zTwyj" style="text-align: right" title="Potentially-dilutive shares">385,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Series H preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_z5hJuykxnD4j" style="text-align: right" title="Potentially-dilutive shares">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_z6i58dGs7Ybj" style="text-align: right" title="Potentially-dilutive shares">1,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Series I preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesIPreferredStockMember_z5jD6xfEntsj" style="text-align: right" title="Potentially-dilutive shares">10,000,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesIPreferredStockMember_zHaIRrpWxbc3" style="text-align: right" title="Potentially-dilutive shares">10,000,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Convertible notes</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zAn0yUhBq4Ui" style="border-bottom: Black 1pt solid; text-align: right" title="Potentially-dilutive shares">631,288,109,671</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zwvPty6AmC6h" style="border-bottom: Black 1pt solid; text-align: right" title="Potentially-dilutive shares">623,636,065,729</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Total</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331_zGqADpeE5qAd" style="text-align: right" title="Potentially-dilutive shares">663,507,515,446</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331_zpqJg1bzqIo8" style="text-align: right" title="Potentially-dilutive shares">653,855,471,504</td><td style="text-align: left"> </td></tr> </table> Management’s Evaluation of Subsequent Events The Company evaluates events that have occurred after the balance sheet date of March 31, 2026, through the date which the condensed consolidated financial statements are issued. Based upon the review, other than described in Note 14 – Subsequent Events, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements. Recent Accounting Pronouncements In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”, which requires greater disaggregation of income tax disclosures related to the income tax rate reconciliation and income taxes paid and effective for fiscal years beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued. The amendments should be applied on a prospective basis although retrospective application is permitted. The Company is currently evaluating the effects of this pronouncement on its financial statements and disclosures. Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying condensed consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying condensed consolidated financial statements include valuation of derivatives and valuation allowance on deferred tax assets.

Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its subsidiaries; the Company’s 50% owned subsidiary GBT Tokenize Corp. All significant intercompany transactions and balances were eliminated.

Cash Equivalents For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly liquid debt instruments with original maturities of three months or less. As of March 31, 2026 and December 31, 2025, the Company did not have any cash equivalents.

Marketable Securities The Company accounts for investment securities in accordance with ASC Topic 321, Investments – equity securities. Marketable equity securities are reported at FV based on quotations available on securities exchanges with any unrealized gain or loss being reported as a component of other income (expense) on the statement of operations. The portion of marketable equity security expected to be sold within 12 months of the balance sheet date is reported as a current asset. These publicly traded equity securities are valued using quoted prices and are included in Level 1.

Derivative Financial Instruments The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its FV and is then re-valued at each reporting date, with changes in the FV reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a binomial option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of March 31, 2026 and December 31, 2025, the Company recorded derivative liabilities of 240,000 and 0, respectively, associated with convertible notes payable due to all the conversion features.

240000

Fair Value of Financial Instruments For certain of the Company’s financial instruments, including cash, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their FV due to their short maturities. FASB ASC Topic 820, Fair Value Measurements and Disclosures, requires disclosure of the FV of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments, defines FV, and establishes a three-level valuation hierarchy for disclosures of FV measurement that enhances disclosure requirements for FV measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. </td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>●</td> <td style="text-align: justify">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. </td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>●</td> <td style="text-align: justify">Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the FV measurement. </td></tr> </table> The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity, and FASB ASC Topic 815, Derivatives and Hedging. For certain financial instruments, the carrying amounts reported in the balance sheets for cash and current liabilities, including convertible notes payable, each qualify as a financial instrument, and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The Company uses Level 2 inputs for its valuation methodology for derivative liabilities as their FV were determined by using the Black-Scholes-Merton pricing model based on various assumptions. The Company’s derivative liabilities are adjusted to reflect FV at each period end, with any increase or decrease in the FV being recorded in results of operations as adjustments to FV of derivatives. At March 31, 2026 and December 31, 2025, the Company identified the following liabilities that are required to be presented on the balance sheet at FV: <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_znXplRi8lMjd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center">Schedule of liabilities to be presented on balance sheet at fair value </td><td> </td> <td colspan="3" style="text-align: center">Fair Value</td><td> </td> <td colspan="11" style="text-align: center">Fair Value Measurements at</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center">As of</td><td> </td> <td colspan="11" style="text-align: center">December 31, 2025</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Description</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">Using Fair Value Hierarchy</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; text-indent: -10pt; padding-left: 10pt">Conversion feature on convertible notes</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_900_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zhs1vEL6WP9e" title="Conversion feature on convertible notes">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_904_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWLoHKK9M2bk" title="Conversion feature on convertible notes">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_901_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJOF0LHXFkTj" title="Conversion feature on convertible notes">—</td><td style="width: 1%; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center">Fair Value</td><td> </td> <td colspan="11" style="text-align: center">Fair Value Measurements at</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center">As of</td><td style="color: #1D2838"> </td> <td colspan="11" style="color: #1D2838; text-align: center">March 31, 2026</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Description</td><td style="color: #1D2838; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; color: #1D2838; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">Using Fair Value Hierarchy</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; text-indent: -10pt; padding-left: 10pt">Conversion feature on convertible notes</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">240,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_90E_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zviDyPUvesz5" title="Conversion feature on convertible notes">240,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_90A_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhKdKdtFXT1j" title="Conversion feature on convertible notes">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_906_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zd7czSwdNuJd" title="Conversion feature on convertible notes">—</td><td style="width: 1%; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_znXplRi8lMjd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center">Schedule of liabilities to be presented on balance sheet at fair value </td><td> </td> <td colspan="3" style="text-align: center">Fair Value</td><td> </td> <td colspan="11" style="text-align: center">Fair Value Measurements at</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center">As of</td><td> </td> <td colspan="11" style="text-align: center">December 31, 2025</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Description</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">Using Fair Value Hierarchy</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; text-indent: -10pt; padding-left: 10pt">Conversion feature on convertible notes</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_900_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zhs1vEL6WP9e" title="Conversion feature on convertible notes">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_904_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWLoHKK9M2bk" title="Conversion feature on convertible notes">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_901_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJOF0LHXFkTj" title="Conversion feature on convertible notes">—</td><td style="width: 1%; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center">Fair Value</td><td> </td> <td colspan="11" style="text-align: center">Fair Value Measurements at</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center">As of</td><td style="color: #1D2838"> </td> <td colspan="11" style="color: #1D2838; text-align: center">March 31, 2026</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Description</td><td style="color: #1D2838; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; color: #1D2838; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">Using Fair Value Hierarchy</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; text-indent: -10pt; padding-left: 10pt">Conversion feature on convertible notes</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">240,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_90E_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zviDyPUvesz5" title="Conversion feature on convertible notes">240,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_90A_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhKdKdtFXT1j" title="Conversion feature on convertible notes">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_906_ecustom--ConversionFeatureOnConvertibleNotes_iI_pp0p0_d0_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zd7czSwdNuJd" title="Conversion feature on convertible notes">—</td><td style="width: 1%; text-align: left"> </td></tr> </table>

0 0 0 0 240000 240000 0 0 Treasury Stock Treasury stock is recorded at cost. The re-issuance of treasury shares is accounted for on a first in, first-out basis and any difference between the cost of treasury shares and the re-issuance proceeds are charged or credited to additional paid-in capital. The Company has 8 treasury stock from acquisitions that commenced in 2011.

Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented and its current on all its tax filings federal and state until 2025 inclusive.

Basic and Diluted Earnings Per Share Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS assumes that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Due to the net income incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented. The following potentially-dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive. <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zSRpT7U6wBlc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">Schedule of potentially- dilutive shares</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Basic outstanding common stock</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zNqgsxVCZ6vk" style="width: 12%; text-align: right" title="Potentially-dilutive shares">22,217,870,775</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zelGxgSahCYd" style="width: 12%; text-align: right" title="Potentially-dilutive shares">20,217,870,775</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Series B preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesBPreferredStockMember_zU2jHvrBBABh" style="text-align: right" title="Potentially-dilutive shares">150,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesBPreferredStockMember_zG10AC2ywYt3" style="text-align: right" title="Potentially-dilutive shares">150,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Series C preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesCPreferredStockMember_zl9O7bjJKOCg" style="text-align: right" title="Potentially-dilutive shares">385,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesCPreferredStockMember_zv1vPv5zTwyj" style="text-align: right" title="Potentially-dilutive shares">385,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Series H preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_z5hJuykxnD4j" style="text-align: right" title="Potentially-dilutive shares">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_z6i58dGs7Ybj" style="text-align: right" title="Potentially-dilutive shares">1,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Series I preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesIPreferredStockMember_z5jD6xfEntsj" style="text-align: right" title="Potentially-dilutive shares">10,000,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesIPreferredStockMember_zHaIRrpWxbc3" style="text-align: right" title="Potentially-dilutive shares">10,000,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Convertible notes</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zAn0yUhBq4Ui" style="border-bottom: Black 1pt solid; text-align: right" title="Potentially-dilutive shares">631,288,109,671</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zwvPty6AmC6h" style="border-bottom: Black 1pt solid; text-align: right" title="Potentially-dilutive shares">623,636,065,729</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Total</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331_zGqADpeE5qAd" style="text-align: right" title="Potentially-dilutive shares">663,507,515,446</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331_zpqJg1bzqIo8" style="text-align: right" title="Potentially-dilutive shares">653,855,471,504</td><td style="text-align: left"> </td></tr> </table> Management’s Evaluation of Subsequent Events The Company evaluates events that have occurred after the balance sheet date of March 31, 2026, through the date which the condensed consolidated financial statements are issued. Based upon the review, other than described in Note 14 – Subsequent Events, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements. Recent Accounting Pronouncements In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”, which requires greater disaggregation of income tax disclosures related to the income tax rate reconciliation and income taxes paid and effective for fiscal years beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued. The amendments should be applied on a prospective basis although retrospective application is permitted. The Company is currently evaluating the effects of this pronouncement on its financial statements and disclosures. Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying condensed consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zSRpT7U6wBlc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">Schedule of potentially- dilutive shares</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Basic outstanding common stock</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zNqgsxVCZ6vk" style="width: 12%; text-align: right" title="Potentially-dilutive shares">22,217,870,775</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zelGxgSahCYd" style="width: 12%; text-align: right" title="Potentially-dilutive shares">20,217,870,775</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Series B preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesBPreferredStockMember_zU2jHvrBBABh" style="text-align: right" title="Potentially-dilutive shares">150,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesBPreferredStockMember_zG10AC2ywYt3" style="text-align: right" title="Potentially-dilutive shares">150,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Series C preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesCPreferredStockMember_zl9O7bjJKOCg" style="text-align: right" title="Potentially-dilutive shares">385,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesCPreferredStockMember_zv1vPv5zTwyj" style="text-align: right" title="Potentially-dilutive shares">385,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Series H preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_z5hJuykxnD4j" style="text-align: right" title="Potentially-dilutive shares">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_z6i58dGs7Ybj" style="text-align: right" title="Potentially-dilutive shares">1,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Series I preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesIPreferredStockMember_z5jD6xfEntsj" style="text-align: right" title="Potentially-dilutive shares">10,000,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesIPreferredStockMember_zHaIRrpWxbc3" style="text-align: right" title="Potentially-dilutive shares">10,000,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Convertible notes</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zAn0yUhBq4Ui" style="border-bottom: Black 1pt solid; text-align: right" title="Potentially-dilutive shares">631,288,109,671</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zwvPty6AmC6h" style="border-bottom: Black 1pt solid; text-align: right" title="Potentially-dilutive shares">623,636,065,729</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Total</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331_zGqADpeE5qAd" style="text-align: right" title="Potentially-dilutive shares">663,507,515,446</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331_zpqJg1bzqIo8" style="text-align: right" title="Potentially-dilutive shares">653,855,471,504</td><td style="text-align: left"> </td></tr> </table>

22217870775

20217870775

150000

385000

1000000

10000000000

631288109671

623636065729

663507515446

653855471504

Management’s Evaluation of Subsequent Events The Company evaluates events that have occurred after the balance sheet date of March 31, 2026, through the date which the condensed consolidated financial statements are issued. Based upon the review, other than described in Note 14 – Subsequent Events, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements.

Recent Accounting Pronouncements In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”, which requires greater disaggregation of income tax disclosures related to the income tax rate reconciliation and income taxes paid and effective for fiscal years beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued. The amendments should be applied on a prospective basis although retrospective application is permitted. The Company is currently evaluating the effects of this pronouncement on its financial statements and disclosures. Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying condensed consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

Note 4 – Marketable Securities <table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--MarketableSecuritiesTableTextBlock_zPa8ijqb2YW" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Marketable Securities (Details)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">Schedule of Marketable Securities</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Marketable Securities from MetAlert Inc.</td><td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--MarketableSecurities_iI_c20260331__dei--LegalEntityAxis__custom--MetAlertIncsMember_zrH5MdMSUWg3" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total Fair Value of Marketable Securities">23</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--MarketableSecurities_iI_c20251231__dei--LegalEntityAxis__custom--MetAlertIncsMember_zD1a0GpewpJh" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total Fair Value of Marketable Securities">8</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Fair Value of Marketable Securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecurities_iI_c20260331_zMORg0VwVkOk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Fair Value of Marketable Securities">23</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--MarketableSecurities_iI_c20251231_zX6i8t9iF6nc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Fair Value of Marketable Securities">8</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> MetAlert (prior name GTX Corp) On April 12, 2022, GBT Tokenize Corp (“GBT Tokenize”), a Nevada corporation which the Company owns 50% of the outstanding shares of common stock, entered into a series of agreements with GTX Corp (“GTX”) and various note holders of GTX pursuant to which Tokenize acquired a convertible promissory note of GTX of $100,000 (the “GTX Notes”). In addition, GBT Tokenize acquired 76,923 (GBT acquired 5,000,000 in the original deal, where GTX to perform a corporate action of 1:65 reverse split on September 20, 2022) shares of common stock of GTX for $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--GTXAgreementMember_z1uVjg3hJiah" title="Number of shares acquired, value">150,000 - in total FV of $12,538 as of December 31, 2022 based on level 1 stock price in OTC markets. The GTX Notes bear 10% interest and 50% of the principal may be converted into shares of common stock on a one-time basis at a conversion price of $0.01 per share. The remaining 50% of the principal must be paid in cash. The closing occurred on April 12, 2022. As of December 31, 2023, the Company wrote off the 50% of the convertible principal with all unpaid interest in total of $65,613 due to the collectability issue. GTX changed its name into Metalert Inc. on or about September 20, 2022. On September 30, 2022, GBT Tokenize, loaned MetAlert Inc., a Nevada corporation (f/k/a GTX Corp.) (“MetAlert”) $90,000. For such loan, MetAlert provided Tokenize a promissory note of $90,000 which is due and payable together with interest of 5% upon the earlier of September 19, 2023 or when declared by Tokenize. As of December 31, 2023, the Company wrote off the entire convertible principal with all unpaid interest in total of $95,770 due to the collectability issue. MetAlert designs, manufactures and sells various interrelated and complementary products and services in the wearable technology and IoMT (Internet of Medical Things) marketplace. As of March 31, 2026 and December 31, 2025, the marketable security had a fair value of $23 and $8, respectively. <table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--MarketableSecuritiesTableTextBlock_zPa8ijqb2YW" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Marketable Securities (Details)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">Schedule of Marketable Securities</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Marketable Securities from MetAlert Inc.</td><td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--MarketableSecurities_iI_c20260331__dei--LegalEntityAxis__custom--MetAlertIncsMember_zrH5MdMSUWg3" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total Fair Value of Marketable Securities">23</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--MarketableSecurities_iI_c20251231__dei--LegalEntityAxis__custom--MetAlertIncsMember_zD1a0GpewpJh" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total Fair Value of Marketable Securities">8</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Fair Value of Marketable Securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecurities_iI_c20260331_zMORg0VwVkOk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Fair Value of Marketable Securities">23</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--MarketableSecurities_iI_c20251231_zX6i8t9iF6nc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Fair Value of Marketable Securities">8</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

0.50

100000

76923

150000

12538

0.01

65613

90000

95770

Note 5 – Impaired Investment Investment in Joint Venture GBT Tokenize Corp On March 6, 2020, the Company through Greenwich, entered into a Joint Venture and Territorial License Agreement (the “Tokenize Agreement”) with Tokenize-It, S.A. (“Tokenize”), which is owned by a Costa Rica Trust represented by Pablo Gonzalez (“Gonzalez”). Gonzalez also represents Gonzalez Costa Rica Trust, which holds a note in the principal amount of $10,000,000 and is also a shareholder of the Company. Under the Tokenize Agreement, the parties formed GBT Tokenize Corp., a Nevada corporation (“GBT Tokenize”). The purpose of GBT Tokenize is to develop, maintain and support source codes for its proprietary technologies including advanced mobile chip technologies, tracking, radio technologies, AI core engine, electronic design automation, mesh, games, data storage, networking, IT services, business process outsourcing development services, customer service, technical support and quality assurance for business, customizable and dedicated inbound and outbound calls solutions, as well as digital communications processing for enterprises and startups (“Technology Portfolio”), throughout the State of California. Upon generating any revenue from the Technology Portfolio, the Joint Venture will earn the first right of refusal for other territories. The Company pledged its 50% ownership in GBT Tokenize and its 100% ownership of Greenwich to Tokenize to secure its Technology Portfolio investment. The Company shall appoint two directors and Tokenize shall appoint one director of GBT Tokenize. Tokenize shall contribute the services and resources for the development of the Technology Portfolio to GBT Tokenize. The Company shall contribute 2,000,000 shares of common stock of the Company (“GBT Shares”) to GBT Tokenize. Tokenize and the Company will each own 50% of GBT Tokenize. The shares were valued at $5,500,000. In addition, GBT Tokenize and Gonzalez entered into a Consulting Agreement in which Gonzalez is engaged to provide services for $33,333 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Gonzalez will provide services in connection with the development of the business as well as GBT Tokenize’s capital raising efforts. The term of the Consulting Agreement is two years. During year ended December 31, 2021, Gonzalez assigned all his accrued balances of $424,731 to Stanley Hills in a private transaction that the Company is not part to. The closing of the Tokenize Agreement occurred on March 9, 2020. Through this Joint Venture the parties commenced development of an intelligent human vital signs’ device, which we currently refer to as the qTerm. The platform is an expansion of the existing license agreement with GBT Tokenize Corp., which provided GBT Tokenize Corp. with an exclusive territory of California to develop certain of the Company’s technology. As the nature of the platform cannot be restricted only to California, the Company’s joint venture GBT Tokenize Corp. will be compensated with additional two hundred million shares of the Company to strengthen its funding, subject to board approval. A provisional patent application for the term Medical Device was filed on March 30, 2020 with the USPTO. The application has been assigned serial number 63001564. The Joint Venture completed successfully the first prototype. There is no guarantee that the Company will be successful in researching, developing or implementing this product into the market. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps. On May 28, 2021, the parties agreed to amend the Tokenize Agreement to expand territory granted for the Technology Portfolio under the license to GBT Tokenize to include the entire continental United States. The Company has further agreed to issue GBT Tokenize an additional 14,000,000 shares of common stock of the Company. The shares were valued at $15,400,000. At March 31, 2020, the Company evaluated the carrying amount of this joint venture investment and determined that this investment was fully impaired and as a result an impairment charge of $5,500,000 was taken. At December 31, 2021, the Company evaluated the carrying amount of this joint venture investment and determined that this investment was fully impaired and as a result an impairment charge of $15,400,000 was taken. On July 20, 2023, the Company through its wholly owned inactive subsidiary, Greenwich International Holdings, a Costa Rica corporation (“Greenwich”), entered into an Amended and Restated Joint Venture (the “2023 Tokenize Agreement”) with Magic Internacional Argentina FC, S.L. (“Magic”) and GBT Tokenize Corp (“GBT Tokenize”). The 2023 Tokenize Agreement restated and replaced the 2022 Tokenize Agreement. Pursuant to the 2023 Tokenize Agreement, as a result of the contribution of the Technology Portfolio by Tokenize and the subsequent contribution of services for the development of the Technology Portfolio by Tokenize and Magic, GBT Tokenize has been able to continue in operation, which has benefited the Company despite its contribution of 166 million shares of common stock valued at approximately $50,000. In order to maintain its 50% ownership interest in GBT Tokenize, the Company agreed to contribute its portfolio of intellectual property to GBT Tokenize and issue to GBT Tokenize <span id="xdx_903_eus-gaap--SharesIssued_iI_c20260331__us-gaap--TypeOfArrangementAxis__custom--TokenizeAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zmRiKWDa14Sk" title="Share issued">1,000 shares of Series I Preferred Stock (the “Series I Stock”) with a stated value of $<span id="xdx_90B_eus-gaap--StockIssued1_c20260101__20260331__us-gaap--TypeOfArrangementAxis__custom--TokenizeAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zEhC3i4vgAMi" title="Issuance of shares value">35,000 per share which is convertible into common stock of the Company by dividing the stated value by the conversion price of $<span id="xdx_905_eus-gaap--PreferredStockConvertibleConversionPrice_iI_c20260331__us-gaap--TypeOfArrangementAxis__custom--TokenizeAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zD7E7OUy7lfj" title="Conversion price">0.0035, which, if converted in full would result in the issuance of <span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_pn9n9_c20260101__20260331__us-gaap--TypeOfArrangementAxis__custom--TokenizeAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_z5Z5GQy1Ayzf" title="Number of shares converted">10 billion shares of common stock of the Company. Further, the Series I Stock will vote on an as converted basis. The Company pledged its 50% ownership in GBT Tokenize and its 100% ownership of Greenwich to Magic to secure its Technology Portfolio investment. Effective as of March 20, 2024, Tokeniz, entered into a Patent Purchase Agreement with VisionWave Technologies Inc. (“VisionWave”) pursuant to which VisionWave agreed to acquire from Tokenize the entire right, title, and interest of certain patents and patent applications providing an intellectual property basis for a machine learning driven technology that controls radio wave transmissions, analyzes their reflections data, and constructs 2D/3D images of stationary and in motion objects (“VisionWave PPA”). The Purchase Price for the asset is $30,000,000 (the “Purchase Price”), which VisionWave will pay with shares of common stock, $0.0001 par value per share (the “Common Stock”). The Parties agree that the final Purchase Price may be adjusted and will be governed by a valuation report issued by a professional third party (“Valuation”). If the final Purchase Price per Valuation is less than $30,000,000, Tokenize has the option to cancel this Agreement. In accordance therewith, VisionWave agreed to issue and deliver to Tokenize, 1,000 shares of Common Stock (the “Shares”) representing 50% of VisionWave’s issued and outstanding shares of Common Stock, where the remainder of the 50% of VisionWave’s issued and outstanding shares of Common Stock are owned by a corporation controlled by Stanley Hills, LLC. Effective June 4, 2024 Tokenize been issued additional 222 from VisionWave for consideration of 10 million AVAI shares that been vested under VisionWave. Although the investment was impaired, the product development is still ongoing. The carrying amount of this investment at March 31, 2026 and December 31, 2025 was $0, respectively.

5500000

33333

424731

14000000

15400000

5500000

166000000

50000

1000

35000

0.0035

10000000000

1 30000000 30000000

Note 6 – Accounts Payable and Accrued Expenses Accounts payable and accrued expenses at March 31, 2026 and December 31, 2025 consist of the following: <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zWnk6JS53Yv1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Payable and Accrued Expenses (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt">Schedule of accounts payable and accrued expenses </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20260331_zFlavSl8YILc" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20251231_zFlsLcj2Uzze" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td></tr> <tr id="xdx_401_eus-gaap--AccountsPayableCurrent_iI_maCzLWa_zLKageaWfcMf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Accounts payable</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">749,893</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">897,008</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_maCzLWa_zto5xuA9zUsl" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Accrued interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">628,906</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">576,284</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iTI_mtCzLWa_zAzPSZOejpjh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,378,799</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,473,292</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Accounts payable consisted of $490,044 aged outstanding balances due to three vendors over 2 years. The increase in accrued liabilities was due to the accrued interest of convertible notes and loan from SBA. <table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfAccountsPayableRelatedPartiesTableTextBlock_zOKITx6w6Dhj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Payable and Accrued Expenses (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"> Schedule of accounts payable related parties </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20260331_zxh7UYIBIfV5" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20251231_zHkYPd0ZNEU" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td></tr> <tr id="xdx_404_ecustom--AccountsPayableRelatedParties_iI_z4cLGWMTUvz1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Accounts payable – related parties</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,146,164</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,146,164</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--AccruedInterestRelatedParties_iI_zIZIa15n3XT4" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Accrued interest - related parties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,139,905</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">233,650</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--OtherPayablesRelatedParties_iI_zRHgZCjdHrS1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other payables - related parties</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,891,101</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,883,744</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--AccountsPayableAndAccruedExpensesRelatedPartyCurrent_iI_zWwvPbCehpJ5" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,286,070</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,263,558</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Accounts payable – related parties consisted of approximately $880,000 aged outstanding balances due to three major related parties for business purpose over 2 years. Accrued interest – related parties consisted of unpaid interest from related parties note payable as of March 31, 2026. Other payables consisted of approximately $1,891,101 advanced payments from three of the related parties for business purposes.

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zWnk6JS53Yv1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Payable and Accrued Expenses (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt">Schedule of accounts payable and accrued expenses </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20260331_zFlavSl8YILc" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20251231_zFlsLcj2Uzze" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td></tr> <tr id="xdx_401_eus-gaap--AccountsPayableCurrent_iI_maCzLWa_zLKageaWfcMf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Accounts payable</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">749,893</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">897,008</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_maCzLWa_zto5xuA9zUsl" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Accrued interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">628,906</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">576,284</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iTI_mtCzLWa_zAzPSZOejpjh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,378,799</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,473,292</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

749893

897008

628906

576284

1378799

1473292

490044

<table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfAccountsPayableRelatedPartiesTableTextBlock_zOKITx6w6Dhj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Payable and Accrued Expenses (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"> Schedule of accounts payable related parties </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20260331_zxh7UYIBIfV5" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20251231_zHkYPd0ZNEU" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td></tr> <tr id="xdx_404_ecustom--AccountsPayableRelatedParties_iI_z4cLGWMTUvz1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Accounts payable – related parties</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,146,164</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,146,164</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--AccruedInterestRelatedParties_iI_zIZIa15n3XT4" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Accrued interest - related parties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,139,905</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">233,650</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--OtherPayablesRelatedParties_iI_zRHgZCjdHrS1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other payables - related parties</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,891,101</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,883,744</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--AccountsPayableAndAccruedExpensesRelatedPartyCurrent_iI_zWwvPbCehpJ5" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,286,070</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,263,558</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1146164 1146164 2139905 233650 1891101 1883744 3286070 3263558 880000 1891101

Note 7 – Convertible Notes Payable, Non-related Parties Convertible notes payable – nonrelated parties at March 31, 2026 and December 31, 2025 consist of the following: <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--RollforwardOfConvertibleNoteTableTextBlock_zu0WoLIuMTP5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Schedule of convertible notes payable – non related parties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="color: #1D2838"> </td> <td colspan="3" style="color: #1D2838; text-align: center">March 31,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="color: #1D2838; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; color: #1D2838; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Convertible note payable to Igor 1 Corp.</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebt_iI_pp0p0_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Igor1CorpMember_z5TXFFbojoc" style="width: 12%; text-align: right" title="Total convertible notes payable, non-related parties">4,812,411</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebt_iI_pp0p0_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Igor1CorpMember_zFCfGxkFVfwi" style="width: 12%; text-align: right" title="Total convertible notes payable, non-related parties">4,812,411</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Convertible notes payable to Glen Eagle</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConvertibleDebt_iI_pp0p0_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlenEagleMember_zqMKReO5x4ol" style="text-align: right" title="Total convertible notes payable, non-related parties">337,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConvertibleDebt_iI_pp0p0_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlenEagleMember_zuCOKBMak4G" style="text-align: right" title="Total convertible notes payable, non-related parties">357,750</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Convertible notes payable to Fleming PLLC</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleDebt_iI_pp0p0_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FlemingPLLCMember_z01N7rTPlvte" style="text-align: right" title="Total convertible notes payable, non-related parties">180,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConvertibleDebt_iI_pp0p0_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FlemingPLLCMember_zE5ottw0bu19" style="text-align: right" title="Total convertible notes payable, non-related parties">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total convertible notes payable, non-related parties</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ConvertibleDebt_iI_pp0p0_c20260331_zSuhk4LpLIB3" style="text-align: right" title="Total convertible notes payable, non-related parties">5,330,161</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ConvertibleDebt_pp0p0_c20251231_zvJDCx2wsnYk" style="text-align: right" title="Total convertible notes payable, non-related parties">5,170,161</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Unamortized debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--DebtInstrumentsUnamortizedDiscountNoncurrent_iI_pp0p0_c20260331_znnAzxA54Bg7" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">(160,626</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_ecustom--DebtInstrumentsUnamortizedDiscountNoncurrent_pp0p0_c20251231_zQom1emwa72j" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Convertible notes payable – nonrelated parties</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--OtherNotesPayableCurrent_iI_pp0p0_c20260331_zLiP5OCuz8w9" style="text-align: right" title="Convertible notes payable - nonrelated parties">5,169,535</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--OtherNotesPayableCurrent_pp0p0_c20251231_zN9X6MNUk8K9" style="text-align: right" title="Convertible notes payable - nonrelated parties">5,170,161</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--LessCurrentPortion_iI_pp0p0_c20260331_ziyKXAtTEic" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(5,150,161</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--LessCurrentPortion_pp0p0_c20251231_zxhBeZJ2YKxk" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(5,170,161</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Convertible notes payable – nonrelated parties, long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--ConvertibleNotesPayableLongtermPortion_iI_pp0p0_c20260331_zFzngyFd04L" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible notes payable - non related parties, long-term portion">19,374</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--ConvertibleNotesPayableLongtermPortion_pp0p0_c20251231_zIjWULDZv5Xf" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible notes payable - non related parties, long-term portion">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> $10,000,000 for GBT Technologies S. A. acquisition – Holder Igor 1 Corp In accordance with the acquisition of GBT-CR the Company issued a convertible note in the principal amount of $<span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTTechnologiesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zZm6km864ZB3" title="Value of share converted">10,000,000. The convertible note bears interest of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTTechnologiesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zd9j1tAD6ntg" title="Note payable, interest rate">6% and is payable at maturity on <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTTechnologiesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_z1mr8JenS2F6" title="Note maturity date">December 31, 2021. At the election of the holder, the convertible note can be converted into a maximum of <span id="xdx_907_eus-gaap--ConversionOfStockSharesConverted1_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTTechnologiesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_z5OvMQkwsRU5" title="Number of shares converted">20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($<span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTTechnologiesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zky2k32iuBZ2" title="Conversion price">500 per share). This convertible note may convert into shares of the Company’s common stock at a conversion price equal to <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentRate_dp_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTTechnologiesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zLECSGtkcwmb" title="Conversion of debt rate">85% of the lowest trading price with a 20-day lookback immediately preceding the date of conversion and therefore recorded as derivative liability. On May 19, 2021, the Company, Gonzalez, GBT-CR and IGOR 1 Corp entered into a Mutual Release and Settlement Agreement and Irrevocable Assignment of outstanding balance plus accrued interest (the “Gonzalez Agreement”). Pursuant to the Gonzalez Agreement, without any party admission of liability and to avoid litigation, the parties had agreed to (i) extend the GBT convertible note maturity date to December 31, 2022, (ii) amend the GBT convertible note terms to include a beneficial ownership blocker of 4.99% and a modified conversion feature to the GBT convertible note with 15% discount to the market price during the 20 trading day period ending on the latest complete trading day prior to the conversion date and (iii) provided for an assignment of the GBT convertible note by Gonzalez to a third party. As a result of the change in terms of this convertible note, the Company took a charge related to the modification of debt of $13,777,480 during the year ended December 31, 2021. This convertible note is recorded as derivative liability because of the discounted price on conversion. During the period ended September 30, 2024, IGOR 1 converted $195,500 of the convertible note into 2,300,000,000 shares of the Company’s common stock. On July 1, 2024, the Company entered into an amendment by and between the Company and IGOR 1 to (1) The Company agrees to transfer 10,000,000 restricted shares of AVAI to the note holder valued at $3,000,000 on the effective date; (2) Amended the conversion price to a fixed price of $0.00001 per share; (3) The total outstanding principal balance including accrued interest shall be adjusted to $4,818,411; and (4) The maximum number of shares that may be issued under the fixed conversion price remain subject to the terms set forth in the original note and shall not be adjusted further by this amendment. The maximum number of shares that can be issued is 481,841,103,000. The Company recognized gain on debt modification of $1,638,163 on the effective date. As of March 31, 2026 and December 31, 2025, the note had an outstanding balance of $4,818,411 and $4,812,411, and accrued interest of $506,042 and $434,845, respectively. Glen Eagle The Company entered into a series of loan arrangements with Glen Eagles Acquisition LP pursuant to which it received $512,500 in loans (the “Debt”) from August 2021 up to September 2022. The original funded amount of $457,500 included convertible feature into shares of the Company’s common stock at a conversion price equal to <span id="xdx_902_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--GlenEaglesAcquisitionLPMember_zEuTInYEqPp4" title="Conversion price">85% of the lowest trading price during the 20-day period preceding the date of conversion. In order to include a convertible feature for the $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_pp0p0_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--GlenEaglesAcquisitionLPMember_zfF89pJgoVO8" title="Convertible feature">55,000 which was not covered by convertible feature, on January 24, 2023, the Company issued a consolidated convertible promissory note to Glen Eagles Acquisition LP in the principal amount of $512,500, which include all prior convertible notes with addition of the $55,000 straight note. The convertible promissory note bears interest of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20230124__us-gaap--BusinessAcquisitionAxis__custom--GlenEaglesAcquisitionLPMember_zLimecLDqna3" title="Note payable, interest rate">10% and is payable at maturity on December 31, 2023. Glen Eagles Acquisition LP may convert the consolidated convertible Note into shares of the Company’s common stock at a conversion price equal to <span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--GlenEaglesAcquisitionLPMember_zBmR9ZdwIzpf" title="Conversion price">85% of the lowest trading price during the 20-day period preceding the date of conversion. The Company recorded a loss on debt extinguishment of $<span id="xdx_903_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_c20260101__20260331__us-gaap--BusinessAcquisitionAxis__custom--GlenEaglesAcquisitionLPMember_z1Wyg2PwpVhc" title="Gain on debt extinguishment">92,737 at the issuance date. During the period ended September 30, 2024, Glen Eagle converted $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20240101__20240930__us-gaap--BusinessAcquisitionAxis__custom--GlenEaglesAcquisitionLPMember_zghNcvGLxm06" title="Number of shares converted, value">170,000 of the convertible note into <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240101__20240930__us-gaap--BusinessAcquisitionAxis__custom--GlenEaglesAcquisitionLPMember_zLzoKn77n5la" title="Number of shares converted, shares">2,000,000,000 shares of the Company’s common stock. On December 31, 2024, the Company entered into an amendment by and between the Company and Glen Eagle to (1) Amended the conversion price to a fixed price of $0.00001 per share; (2) The total outstanding principal balance including accrued interest shall be adjusted to $349,157; and (4) The maximum number of shares that may be issued under the fixed conversion price remain subject to the terms set forth in the original note and shall not be adjusted further by this amendment. The maximum number of share that can be issued is 37,500,000,000. The Company recognized gain on debt modification of $156,833 on the effective date. On February 5, 2026, the Company entered into a Settlement Agreement (the “Settlement Agreement”) with a service provider. Pursuant to the Settlement Agreement, the Company settled $180,000 in accrued and unpaid legal fees owed to the service provided for services rendered from February 2023 through January 2026 by issuing a Convertible Promissory Note in the principal amount of $180,000 (the “Note”). The Note matures on June 30, 2027 and bears interest at 8% per annum (increasing to 12% upon an event of default). The Note is convertible at any time, in whole or in part, at the holder’s option, into shares of the Company’s common stock, par value $0.00001 per share, at a conversion price equal to the lower of (i) $0.0001 per share or (ii) 50% of the average of the ten (10) lowest closing bid prices during the ten (10) consecutive trading days immediately preceding the conversion date, provided that the conversion price shall in no event be less than $0.00001 per share (the “Floor Price”). The Note contains customary anti-dilution adjustments for stock splits, dividends and similar events, but the Floor Price is not subject to adjustment. The Note includes a 4.99% beneficial ownership limitation (which may be increased to 9.99% upon 61 days’ prior notice by the holder) and may be prepaid only with the written consent of the holder. Upon issuance of the Note, all claims related to the settled legal fees were fully released by both parties, with no admission of liability. As of March 31, 2026 and December 31, 2025, the consolidated convertible note had an outstanding balance of $337,750 and $375,000 and an accrued interest of $44,664 and $35,466, respectively. Fleming PLLC On February 5, 2026, the Company entered into a settlement agreement with Fleming PLLC, a New York professional limited liability company, to settle and resolve the legal services to the Company which has issued an invoice dated January 21, 2026 in the total amount of $180,000 for services rendered from February 2023 through January 2026. In consideration for the settlement of the outstanding amount, the Company has agreed to issue a convertible promissory note in the principal amount of $180,000 to Fleming PLLC. The principal amount shall bear interest at the rate of 8% per annum, with a maturity date on June 30, 2027. The Note is convertible at any time, in whole or in part, at the holder’s option, into shares of the Company’s common stock, par value $0.00001 per share, at a conversion price equal to the lower of (i) $0.0001 per share or (ii) 50% of the average of the ten (10) lowest closing bid prices during the ten (10) consecutive trading days immediately preceding the conversion date, provided that the conversion price shall in no event be less than $0.00001 per share (the “Floor Price”). The Note contains customary anti-dilution adjustments for stock splits, dividends and similar events, but the Floor Price is not subject to adjustment. The Note includes a 4.99% beneficial ownership limitation (which may be increased to 9.99% upon 61 days’ prior notice by the holder) and may be prepaid only with the written consent of the holder. Upon issuance of the Note, all claims related to the settled legal fees were fully released by both parties, with no admission of liability. As of March 31, 2026 and December 31, 2025, the convertible note had an outstanding balance of $180,000 and $0 and an accrued interest of $2,170 and $0, respectively.

<table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--RollforwardOfConvertibleNoteTableTextBlock_zu0WoLIuMTP5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Schedule of convertible notes payable – non related parties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="color: #1D2838"> </td> <td colspan="3" style="color: #1D2838; text-align: center">March 31,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="color: #1D2838; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; color: #1D2838; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Convertible note payable to Igor 1 Corp.</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebt_iI_pp0p0_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Igor1CorpMember_z5TXFFbojoc" style="width: 12%; text-align: right" title="Total convertible notes payable, non-related parties">4,812,411</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebt_iI_pp0p0_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Igor1CorpMember_zFCfGxkFVfwi" style="width: 12%; text-align: right" title="Total convertible notes payable, non-related parties">4,812,411</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Convertible notes payable to Glen Eagle</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConvertibleDebt_iI_pp0p0_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlenEagleMember_zqMKReO5x4ol" style="text-align: right" title="Total convertible notes payable, non-related parties">337,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConvertibleDebt_iI_pp0p0_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlenEagleMember_zuCOKBMak4G" style="text-align: right" title="Total convertible notes payable, non-related parties">357,750</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Convertible notes payable to Fleming PLLC</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleDebt_iI_pp0p0_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FlemingPLLCMember_z01N7rTPlvte" style="text-align: right" title="Total convertible notes payable, non-related parties">180,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConvertibleDebt_iI_pp0p0_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FlemingPLLCMember_zE5ottw0bu19" style="text-align: right" title="Total convertible notes payable, non-related parties">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total convertible notes payable, non-related parties</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ConvertibleDebt_iI_pp0p0_c20260331_zSuhk4LpLIB3" style="text-align: right" title="Total convertible notes payable, non-related parties">5,330,161</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ConvertibleDebt_pp0p0_c20251231_zvJDCx2wsnYk" style="text-align: right" title="Total convertible notes payable, non-related parties">5,170,161</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Unamortized debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--DebtInstrumentsUnamortizedDiscountNoncurrent_iI_pp0p0_c20260331_znnAzxA54Bg7" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">(160,626</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_ecustom--DebtInstrumentsUnamortizedDiscountNoncurrent_pp0p0_c20251231_zQom1emwa72j" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Convertible notes payable – nonrelated parties</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--OtherNotesPayableCurrent_iI_pp0p0_c20260331_zLiP5OCuz8w9" style="text-align: right" title="Convertible notes payable - nonrelated parties">5,169,535</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--OtherNotesPayableCurrent_pp0p0_c20251231_zN9X6MNUk8K9" style="text-align: right" title="Convertible notes payable - nonrelated parties">5,170,161</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--LessCurrentPortion_iI_pp0p0_c20260331_ziyKXAtTEic" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(5,150,161</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--LessCurrentPortion_pp0p0_c20251231_zxhBeZJ2YKxk" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(5,170,161</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Convertible notes payable – nonrelated parties, long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--ConvertibleNotesPayableLongtermPortion_iI_pp0p0_c20260331_zFzngyFd04L" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible notes payable - non related parties, long-term portion">19,374</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--ConvertibleNotesPayableLongtermPortion_pp0p0_c20251231_zIjWULDZv5Xf" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible notes payable - non related parties, long-term portion">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

4812411

337750

357750

180000

5330161

5170161

-160626

5169535

5170161

-5150161 -5170161 19374

10000.00

0.06

2021-12-31

20000

500

0.85

2022-12-31

13777480 IGOR 1 converted $195,500 of the convertible note into 2,300,000,000 shares of the Company’s common stock. (1) The Company agrees to transfer 10,000,000 restricted shares of AVAI to the note holder valued at $3,000,000 on the effective date; (2) Amended the conversion price to a fixed price of $0.00001 per share; (3) The total outstanding principal balance including accrued interest shall be adjusted to $4,818,411; and (4) The maximum number of shares that may be issued under the fixed conversion price remain subject to the terms set forth in the original note and shall not be adjusted further by this amendment. The maximum number of shares that can be issued is 481,841,103,000. The Company recognized gain on debt modification of $1,638,163 on the effective date.

4818411

4812411

506042 434845

512500

457500

0.85

55000

512500

55000

0.10

2023-12-31

0.85

92737

170000

2000000000

(1) Amended the conversion price to a fixed price of $0.00001 per share; (2) The total outstanding principal balance including accrued interest shall be adjusted to $349,157; and (4) The maximum number of shares that may be issued under the fixed conversion price remain subject to the terms set forth in the original note and shall not be adjusted further by this amendment. The maximum number of share that can be issued is 37,500,000,000. The Company recognized gain on debt modification of $156,833 on the effective date.

180000

337750

375000

44664

35466

180000

2170

Note 8 – Loan Payable, Non-related Parties Loan payable, non-related parties at March 31, 2026 and December 31, 2025 consist of the following: <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--NotesPayableTableTextBlock_zKE6DEVFc7O9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loan Payable, Non-related Parties (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt">Schedule of loan payable, non-related parties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="color: #1D2838"> </td> <td colspan="3" style="color: #1D2838; text-align: center">March 31,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="color: #1D2838; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; color: #1D2838; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">SBA loan</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--TotalNotesPayable_iI_pp0p0_c20260331__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_z1jYlaaVhRa2" style="width: 12%; text-align: right" title="Total notes payable">350,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_ecustom--TotalNotesPayable_pp0p0_c20251231__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_zvmqfdu0lId6" style="width: 12%; text-align: right" title="Total notes payable">350,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Glen Eagle Promissory Note</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--TotalNotesPayable_iI_pp0p0_c20260331__us-gaap--DebtInstrumentAxis__custom--GlenEaglePromissoryNoteMember_zusFijqD1xWa" style="border-bottom: Black 1pt solid; text-align: right" title="Total notes payable">83,637</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--TotalNotesPayable_iI_pp0p0_c20251231__us-gaap--DebtInstrumentAxis__custom--GlenEaglePromissoryNoteMember_zTxFUAzgSBn6" style="border-bottom: Black 1pt solid; text-align: right" title="Total notes payable">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total loan payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--TotalNotesPayables_iI_pp0p0_c20260331_zFqAV85XK3r2" style="text-align: right" title="Total notes payable">433,637</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--TotalNotesPayables_pp0p0_c20251231_zGZFSRHIbEs5" style="text-align: right" title="Total notes payable">350,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Unamortized debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--DebtInstrumentsUnamortizedDiscountCurrent_iI_pp0p0_c20260331_zETDUUcpBO7f" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--DebtInstrumentsUnamortizedDiscountCurrent_pp0p0_c20251231_zOTNZkQ5UNOb" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Loan payable, net of debt discount</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--LoanPayableNetOfDebtDiscount_iI_pp0p0_c20251231_zSWC9xnMLj5g" style="text-align: right" title="Loan payable, net of debt discount">350,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--CurrentPortionOfNotesPayables_iI_pp0p0_c20260331_zuOWtXx1VEN5" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_ecustom--CurrentPortionOfNotesPayables_pp0p0_c20251231_zwdAOE8oTi28" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Loan payable, long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_ecustom--LongTermNotePayables_iI_pp0p0_c20260331_zuR7EgiZ3RAg" style="border-bottom: Black 2.5pt double; text-align: right" title="Loan payable, long-term portion">433,637</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_ecustom--LongTermNotePayables_iI_pp0p0_c20251231_zP8bhlMRNwQb" style="border-bottom: Black 2.5pt double; text-align: right" title="Loan payable, long-term portion">350,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> SBA Loan On June 22, 2020, the Company received a loan from the Small Business Administration under the Economic Injury Disaster Loan program related to the COVID-19 relief efforts. The loan bears interest at <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200621__20200622__us-gaap--LongtermDebtTypeAxis__custom--EIDLMember__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_zYqoW9GmaJue" title="Interest rate">3.75%, requires monthly principal and interest payments of $<span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPayment_c20200621__20200622__us-gaap--LongtermDebtTypeAxis__custom--EIDLMember__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_zP3tHSYyp1y6" title="Principal periodic payments">731 after 12 months from funding and is due <span id="xdx_906_eus-gaap--DebtInstrumentTerm_dtD_c20200621__20200622__us-gaap--LongtermDebtTypeAxis__custom--EIDLMember__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_z7OKNCLJKlWf" title="Payment term">30 years from the date of issuance. The monthly payments have been extended by the SBA to all EIDL borrowers with additional 12 months. Monthly payments will be commenced on or around June 16, 2022. On October 1, 2021, the Company entered an Amended Loan Authorization and Agreement with the SBA providing for the modification of the Original Note providing for monthly principal and interest payments of $1,771 after 24 months from the Original Note commencing on or around June 22, 2022. On March 17, 2022 the SBA notified it deferred the payments to all COVID-19 EIDL loans will have the first payment due extended from 24-months to 30-months from the date of the note. The Modified Note will continue to bear interest at 3.75% and is due 30 years from the date of issuance of the Original Note. The Modified Note is guaranteed by Douglas Davis, the former CEO of the Company and current consultant, as well as by GBT Tokenize Corp. The additional funding of $200,000 was received by the Company on October 5, 2021. The current portion of principal balance of the loan at March 31, 2026 and December 31, 2025 was $83,637 and $0 plus accrued interest of $76,030 and $72,349, respectively. The noncurrent portion of principal balance of the note at March 31, 2026 and December 31, 2025 was $350,000 and $350,000, respectively. The Company did not make any payment on the loan and seeking hardship from the SBA for reduce payment which was not yet addressed by the SBA. <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--NotesPayableTableTextBlock_zKE6DEVFc7O9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loan Payable, Non-related Parties (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt">Schedule of loan payable, non-related parties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="color: #1D2838"> </td> <td colspan="3" style="color: #1D2838; text-align: center">March 31,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="color: #1D2838; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; color: #1D2838; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">SBA loan</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--TotalNotesPayable_iI_pp0p0_c20260331__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_z1jYlaaVhRa2" style="width: 12%; text-align: right" title="Total notes payable">350,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_ecustom--TotalNotesPayable_pp0p0_c20251231__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_zvmqfdu0lId6" style="width: 12%; text-align: right" title="Total notes payable">350,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Glen Eagle Promissory Note</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--TotalNotesPayable_iI_pp0p0_c20260331__us-gaap--DebtInstrumentAxis__custom--GlenEaglePromissoryNoteMember_zusFijqD1xWa" style="border-bottom: Black 1pt solid; text-align: right" title="Total notes payable">83,637</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--TotalNotesPayable_iI_pp0p0_c20251231__us-gaap--DebtInstrumentAxis__custom--GlenEaglePromissoryNoteMember_zTxFUAzgSBn6" style="border-bottom: Black 1pt solid; text-align: right" title="Total notes payable">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total loan payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--TotalNotesPayables_iI_pp0p0_c20260331_zFqAV85XK3r2" style="text-align: right" title="Total notes payable">433,637</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--TotalNotesPayables_pp0p0_c20251231_zGZFSRHIbEs5" style="text-align: right" title="Total notes payable">350,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Unamortized debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--DebtInstrumentsUnamortizedDiscountCurrent_iI_pp0p0_c20260331_zETDUUcpBO7f" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--DebtInstrumentsUnamortizedDiscountCurrent_pp0p0_c20251231_zOTNZkQ5UNOb" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Loan payable, net of debt discount</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--LoanPayableNetOfDebtDiscount_iI_pp0p0_c20251231_zSWC9xnMLj5g" style="text-align: right" title="Loan payable, net of debt discount">350,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--CurrentPortionOfNotesPayables_iI_pp0p0_c20260331_zuOWtXx1VEN5" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_ecustom--CurrentPortionOfNotesPayables_pp0p0_c20251231_zwdAOE8oTi28" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Loan payable, long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_ecustom--LongTermNotePayables_iI_pp0p0_c20260331_zuR7EgiZ3RAg" style="border-bottom: Black 2.5pt double; text-align: right" title="Loan payable, long-term portion">433,637</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_ecustom--LongTermNotePayables_iI_pp0p0_c20251231_zP8bhlMRNwQb" style="border-bottom: Black 2.5pt double; text-align: right" title="Loan payable, long-term portion">350,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 350000 350000 83637 433637 350000 350000 433637 350000

0.0375

731

P30D

1771

0.0375

200000

83637

76030

72349

350000

Note 9 – Note Payable, Non-related Parties Glen Eagle Promissory Note On February 6, 2026, the Company entered into a promissory note agreement with Glen Eagles Acquisition L.P., a Delaware limited partnership in the total principal amount of $83,636. The note bears interest at 3.66% per annum and is due after one year anniversary. As of March 31, 2026 and December 31, 2025, the promissory note had an outstanding balance of $<span id="xdx_905_eus-gaap--RepaymentOfNotesReceivableFromRelatedParties_c20260101__20260331__us-gaap--RelatedPartyTransactionAxis__custom--GlenEaglePromissoryNoteMember_zxnInRiu0l7c" title="Promissory note">83,636 and $<span id="xdx_90C_eus-gaap--RepaymentOfNotesReceivableFromRelatedParties_c20250101__20251231__us-gaap--RelatedPartyTransactionAxis__custom--GlenEaglePromissoryNoteMember_zBVRJRYkimB4" title="Promissory note">0, and an accrued interest of $444 and $0, respectively.

83636

3.66

83636

444 0

Note 10 – Related Party Transactions Convertible notes payable – related parties at March 31, 2026 and December 31, 2025 consist of the following: <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ConvertibleDebtTableTextBlock_zcxQ8HMLIx4g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt">Schedule of convertible note payable – related parties</td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20260331_zyp55CbND0H7" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20251231_zLmo90RYui3k" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="color: #1D2838"> </td> <td colspan="3" style="color: #1D2838; text-align: center">March 31,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td></tr> <tr id="xdx_408_ecustom--ConvertibleNotePayableToStanleyHills_iI_zkMZAXu0qv8f" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Convertible note payable to Stanley Hills</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">474,599</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">474,599</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--UnamortizedDebtDiscountAtConvertibleNotePayable_iI_d0_zxpY4llbTYUc" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Unamortized debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--OtherConvertibleNotesPayableCurrent_iI_zysYQ8HRuzJa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Convertible notes payable, net, related party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">474,599</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">474,599</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--LessCurrentPortionOfConvertibleNotePayable_iI_zVmmvIlp59ni" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(474,599</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(474,599</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_405_ecustom--ConvertibleNotesPayableNetRelatedPartyLongtermPortion_iI_d0_zDgkHbrT7i75" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Convertible notes payable, net, related party, long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Stanley Hills LLC The Company entered into a series of loan agreements with Stanley Hills LLC (“Stanley”) pursuant to which it received more than $1,000,000 in loans (the “Debt”) from May 2019 up to December 2019. On February 26, 2020, in order to induce Stanley to continue to provide funding, the Company and Stanley entered into a letter agreement providing that the current note payable balance due to Stanley of $1,214,900 may be converted into shares of common stock of the Company at a conversion price equal to <span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_c20200225__20200226__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zyjI24FqUqAh" title="Conversion price">85% multiplied by the lowest one trading price for the common stock during the 20-trading day period ending on the latest complete trading day prior to the conversion date. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. Stanley had agreed to restrict its ability to convert the Debt and receive shares of common stock such that the number of shares of common stock held by it and its affiliates after such conversion or exercise does not exceed <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200225__20200226__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zUsQhae26128" title="Interest rate">4.99% of the then issued and outstanding shares of common stock. During the year ended December 31, 2021, Stanley converted $1,231,466 of its convertible note plus interest into 4,420,758 shares of the Company’s common stock, and during the year ended December 31, 2021, Stanley loaned the Company an additional $325,000. Also, during the year ended December 31, 2021, the Company transferred the SURG shares received as repayment of $800,000 of this convertible note and also converted $<span id="xdx_901_eus-gaap--ConvertibleDebt_iI_pp0p0_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zZlMxwuNwtnb" title="Convertible debt">126,003 of accrued interest into the principal balance. During the year ended December 31, 2021, Gonzalez assigned all his accrued balances of $424,731 to Stanley in a private transaction that the Company is not part to (See Note 10). On January 2, 2023, the Company issued a convertible promissory note to Stanley for its credit balances in the principal amount of $750,000. The convertible promissory note bears interest of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20230102__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zjOfHPgSwFRl" title="Interest rate">10% and is payable at maturity on September 30, 2024. Stanley may convert the consolidated convertible Note into shares of the Company’s common stock at a conversion price equal to <span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_c20230101__20230102__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zS6JiHPqMV0e" title="Conversion price">85% of the lowest trading price during the 20-day period preceding the date of conversion. The Company recorded a gain on debt extinguishment of $<span id="xdx_901_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zQ2mFpRPZjZh" title="Gain on debt extinguishment">408,034 at the issuance date. During the period ended September 30, 2024, Stanley Hills converted $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20250101__20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zKl0RVgKi96h" title="Number of shares converted, value">170,000 of the convertible note into <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250101__20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zYsKE4b17Db" title="Number of shares converted, shares">2,000,000,000 shares of the Company’s common stock. On December 31, 2024, the Company entered into an amendment by and between the Company and Stanley Hills LLC to <span id="xdx_909_ecustom--ReductionOfOutstandingBalanceDescription_c20250101__20250331__dei--LegalEntityAxis__custom--StanleyHillsLLCMember_zH202QwJ2Ti4" title="Reduction of outstanding balance description">(1) Extended the maturity date of the note to December 31, 2025; (2) Amended the conversion price to a fixed price of $0.00001 per share; (3) The total outstanding principal balance including accrued interest shall be adjusted to $600,000; and (4) The maximum number of shares that may be issued under the fixed conversion price remain subject to the terms set forth in the original note and shall not be adjusted further by this amendment. The maximum number of shares that can be issued is 60,000,000,000. The Company recognized gain on debt modification of $250,054 on the effective date. During the year ended December 31, 2025, Stanley Hills converted $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20250101__20250331__dei--LegalEntityAxis__custom--StanleyHillsLLCMember_zWQUI29xQ5hh" title="Reduction of outstanding balance description">16,796 of the convertible note into <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_z6yCH7wCz1P9" title="Number of shares converted, shares">1,679,641,595 shares of the Company’s common stock. As of March 31, 2026 and December 31, 2025, the principal balance of Stanley debt was $474,599 and $474,599 respectively. The unpaid interest of the Stanley debt at March 31, 2026 and December 31, 2025 was $168,550 and $156,847, respectively. Notes payable, related party at March 31, 2026 and December 31, 2025 consist of the following: <table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfNotePayableRelatedPartiesTableTextblock_zYPZglnXMYUe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"> Schedule of Notes payable, related party </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="color: #1D2838"> </td> <td colspan="3" style="color: #1D2838; text-align: center">March 31,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Alpha Eda Note payable</td><td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--TotalNotesPayableRelatedParty_iI_pp0p0_c20260331__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_zzceR8iiZWeb" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total notes payable, related party">140,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--TotalNotesPayableRelatedParty_pp0p0_c20251231__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_zLKJZtvDpnZ2" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total notes payable, related party">140,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total notes payable, related party</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--TotalNotesPayableRelatedParty_iI_pp0p0_c20260331_z938RdELfbz6" style="text-align: right" title="Total notes payable, related party">140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--TotalNotesPayableRelatedParty_pp0p0_c20251231_zqvm7ejd7yui" style="text-align: right" title="Total notes payable, related party">140,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Unamortized debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--DebtInstrumentsUnamortizedDiscountCurrents_iI_pp0p0_c20260331_z1H4vF6qaqEe" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--DebtInstrumentsUnamortizedDiscountCurrents_pp0p0_c20251231_zvtmCGligEw2" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes payable, net, related party</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--NotesPayableRelatedParties_iI_pp0p0_c20260331_zXH7FpH3gduj" style="text-align: right" title="Notes payable, net, related party">140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--NotesPayableRelatedParties_pp0p0_c20251231_zcVDWc6LiZ15" style="text-align: right" title="Notes payable, net, related party">140,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--CurrentPortionOfNotePayableRelatedParties_iI_pp0p0_c20260331_zzGAODpS1wx" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--CurrentPortionOfNotePayableRelatedParties_pp0p0_c20251231_zsTlE9pIWhvi" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes payable, net, related party, long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--NotesPayableNetRelatedPartyLongtermPortion_iI_pp0p0_c20260331_zzFMvXVd8A3i" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, net, related party, long-term portion">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--NotesPayableNetRelatedPartyLongtermPortion_pp0p0_c20251231_zSnJhGCNAdfb" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, net, related party, long-term portion">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Alpha Eda On November 15, 2020, the Company issued a promissory note to Alpha Eda, LLC (“Alpha”), a related party for $140,000. The note accrues interest at 10%, is unsecured and was due on September 30, 2021. On December 31, 2024 Alpha and the Company extended the note maturity to December 31, 2025. The balance of the note at March 31, 2026 and December 31, 2025 was $140,000 and $140,000 plus accrued interest of $80,225 and $76,803, respectively.

<table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ConvertibleDebtTableTextBlock_zcxQ8HMLIx4g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt">Schedule of convertible note payable – related parties</td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20260331_zyp55CbND0H7" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20251231_zLmo90RYui3k" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="color: #1D2838"> </td> <td colspan="3" style="color: #1D2838; text-align: center">March 31,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td></tr> <tr id="xdx_408_ecustom--ConvertibleNotePayableToStanleyHills_iI_zkMZAXu0qv8f" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Convertible note payable to Stanley Hills</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">474,599</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">474,599</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--UnamortizedDebtDiscountAtConvertibleNotePayable_iI_d0_zxpY4llbTYUc" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Unamortized debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--OtherConvertibleNotesPayableCurrent_iI_zysYQ8HRuzJa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Convertible notes payable, net, related party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">474,599</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">474,599</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--LessCurrentPortionOfConvertibleNotePayable_iI_zVmmvIlp59ni" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(474,599</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(474,599</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_405_ecustom--ConvertibleNotesPayableNetRelatedPartyLongtermPortion_iI_d0_zDgkHbrT7i75" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Convertible notes payable, net, related party, long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

474599 474599 0 0 474599 474599 -474599 -474599 0 0

1000000

1214900

0.85

0.0499

1231466

4420758

325000

800000

126.00

424731

750000

0.10

2024-09-30

0.85

408034

170000

2000000000

(1) Extended the maturity date of the note to December 31, 2025; (2) Amended the conversion price to a fixed price of $0.00001 per share; (3) The total outstanding principal balance including accrued interest shall be adjusted to $600,000; and (4) The maximum number of shares that may be issued under the fixed conversion price remain subject to the terms set forth in the original note and shall not be adjusted further by this amendment. The maximum number of shares that can be issued is 60,000,000,000. The Company recognized gain on debt modification of $250,054 on the effective date.

16796

1679641595

474599

168550 156847 <table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfNotePayableRelatedPartiesTableTextblock_zYPZglnXMYUe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"> Schedule of Notes payable, related party </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="color: #1D2838"> </td> <td colspan="3" style="color: #1D2838; text-align: center">March 31,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Alpha Eda Note payable</td><td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--TotalNotesPayableRelatedParty_iI_pp0p0_c20260331__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_zzceR8iiZWeb" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total notes payable, related party">140,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--TotalNotesPayableRelatedParty_pp0p0_c20251231__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_zLKJZtvDpnZ2" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total notes payable, related party">140,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total notes payable, related party</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--TotalNotesPayableRelatedParty_iI_pp0p0_c20260331_z938RdELfbz6" style="text-align: right" title="Total notes payable, related party">140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--TotalNotesPayableRelatedParty_pp0p0_c20251231_zqvm7ejd7yui" style="text-align: right" title="Total notes payable, related party">140,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Unamortized debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--DebtInstrumentsUnamortizedDiscountCurrents_iI_pp0p0_c20260331_z1H4vF6qaqEe" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--DebtInstrumentsUnamortizedDiscountCurrents_pp0p0_c20251231_zvtmCGligEw2" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes payable, net, related party</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--NotesPayableRelatedParties_iI_pp0p0_c20260331_zXH7FpH3gduj" style="text-align: right" title="Notes payable, net, related party">140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--NotesPayableRelatedParties_pp0p0_c20251231_zcVDWc6LiZ15" style="text-align: right" title="Notes payable, net, related party">140,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--CurrentPortionOfNotePayableRelatedParties_iI_pp0p0_c20260331_zzGAODpS1wx" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--CurrentPortionOfNotePayableRelatedParties_pp0p0_c20251231_zsTlE9pIWhvi" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes payable, net, related party, long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--NotesPayableNetRelatedPartyLongtermPortion_iI_pp0p0_c20260331_zzFMvXVd8A3i" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, net, related party, long-term portion">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--NotesPayableNetRelatedPartyLongtermPortion_pp0p0_c20251231_zSnJhGCNAdfb" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, net, related party, long-term portion">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 140000 140000 140000 140000 140000 140000 -140000 -140000 140000

140000

80225

76803

Note 11 - Stockholders’ Equity Common Stock In July 7, 2022 the Company filed a preliminary information statement to the stockholders of record (the “Record Date”) in connection with certain actions to be taken by the written consent by stockholders holding a majority of the voting stock of the Company, dated as of June 28, 2022. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">To amend the Company’s Articles of Incorporation, (the “Articles of Incorporation”) to increase the number of authorized shares of common stock, par value $0.00001 per share (the “Common Stock”), of the Company from 2,000,000,000 shares to 10,000,000,000 shares. This action concluded on August 11, 2022.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">(i) authorize the Company’s Board of Directors to effect, in its sole discretion, a reverse stock split of the Common Stock in a ratio of up to 1-for-500 (the “Reverse Stock Split”), and (ii) authorize the filing of an amendment to the Company’s Articles of Incorporation to implement the Reverse Stock Split and any other action deemed necessary to effectuate the Reverse Stock Split, without further approval or authorization of stockholders, at any time prior to December 31, 2023. This action was not commenced yet by the Company’s board. </td></tr> </table> On October 12, 2023, the Company amended its articles of incorporation to increase its authorized shares of common stock to 30,000,000,000 (the “Increase Amendment”). The Increase Amendment was approved by the board of directors as well as the shareholders holding in excess of a majority of the issued and outstanding voting shares of the Company. During the year ended December 31, 2024, the Company had the following transactions in its common stock: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Of 6,559,534,118 shares issued for the conversion of convertible notes of $555,680 and accrued interest of $1,880.</td></tr> </table> During the year ended December 31, 2025, the Company had the following transactions in its common stock: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Of 3,404,641,595 shares issued for the conversion of convertible notes of $34,046.</td></tr> </table> During the three months ended March 31, 2026, the Company had the following transactions in its common stock: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Of 2,000,000,000 shares issued for the conversion of convertible notes of $20,000.</td></tr> </table> As of March 31, 2026 and December 31, 2025, there were 22,217,870,775 and 20,217,870,775 shares of common stock issued and outstanding, respectively. Series B Preferred Shares The Series B Preferred Stock has a stated value of $100 per share and is convertible into the Company’s common stock at a conversion price of $30 per share representing 3,000 posts reverse split common shares. Furthermore, the Series B Preferred Stock votes on an as converted basis and carries standard anti-dilution rights. These rights were subsequently removed, except in cases of stock dividends or splits. As of March 31, 2026 and December 31, 2025, there were 45,000 and 45,000 Series B Preferred Shares outstanding, respectively. Series C Preferred Shares Each share of Series C Preferred Stock is convertible, at the option of GV, into such number of shares of common stock of the Company as determined by dividing the Stated Value (as defined below) by the Conversion Price (as defined below). The Conversion Price for each share is equal to a 50% discount to the average of the lowest three lowest closing bid prices of the Company’s common stock during the 10-day trading period prior to the conversion with a minimum conversion price of $0.02. The stated value is $11 per share (the “Stated Value”). The Series C Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series C Preferred Stock shall be entitled to one vote for each share of common stock that the Series C Preferred Stock shall be convertible into. GV has contractually agreed to restrict its ability to convert the Series C Preferred Stock and receive shares of the Company’s common stock such that the number of shares of the Company’s common stock held by it and its affiliates after such conversion does not exceed 4.9% of the then issued and outstanding shares of the Company’s common stock. The issuance of the Series C Preferred Stock was made in reliance upon exemptions from registration pursuant to Section 4(a)(2) under the Securities Act of 1933 and Rule 506 promulgated under Regulation D thereunder. GV is an accredited investor as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933. At March 31, 2026 and December 31, 2025, GV owns 700 and 700 Series C Preferred Shares, respectively. Series H Preferred Shares On June 17, 2019, the Company, AltCorp Trading LLC, a Costa Rica company and a wholly-owned subsidiary of the Company (“AltCorp”), GBT Technologies, S.A., a Costa Rica company (“GBT-CR”) and Pablo Gonzalez, a shareholder’s representative of GBT-CR (“Gonzalez”), entered into and closed an Exchange Agreement (the “GBT Exchange Agreement”) pursuant to which the parties exchanged certain securities. In accordance with the Exchange Agreement, AltCorp acquired <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20190616__20190617__dei--LegalEntityAxis__custom--AltcorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zJMR9HcKqsS7" title="Stock issued for acquisitions, shares">625,000 shares of GBT-CR representing 25% of its issued and outstanding shares of common stock from Gonzalez for the issuance of <span id="xdx_909_eus-gaap--ConversionOfStockSharesConverted1_c20190616__20190617__dei--LegalEntityAxis__custom--AltcorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zQaA6j57rBsa" title="Number of shares converted">20,000 shares of Series H Convertible Preferred Stock of the Company and a Convertible Note of $<span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190616__20190617__dei--LegalEntityAxis__custom--AltcorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zAInAptb0rhi" title="Debt conversion converted instrument, value">10,000,000 issued by the Company (the “Gopher Convertible Note”) as well as additional consideration. The Gopher Convertible Note bears interest of 6% and is payable at maturity on <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20190616__20190617__dei--LegalEntityAxis__custom--AltcorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zpWuGuekKAUi" title="Maturity date">December 31, 2021. At the election of Gonzalez, the Gopher Convertible Note can be converted into a maximum of <span id="xdx_90F_eus-gaap--ConversionOfStockSharesConverted1_c20190616__20190617__dei--LegalEntityAxis__custom--AltcorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_z1t70fMR273d" title="Number of shares converted">20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($<span id="xdx_90D_eus-gaap--DividendsPayableAmountPerShare_c20190617__dei--LegalEntityAxis__custom--AltcorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_pdd" title="Dividend per share">500 per share) by the conversion price ($10 per share). The Series H Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series H Preferred Stock shall be entitled to one vote for each share of common stock that the Series H Preferred Stock may be convertible into. As of March 31, 2026 and December 31, 2025, there are 20,000 and 20,000 shares of Series H Preferred Shares outstanding, respectively. Series I Preferred Shares On July 20, 2023, the Company through its wholly owned subsidiary, Greenwich International Holdings, a Costa Rica corporation (“Greenwich”), entered into an Amended and Restated Joint Venture (the “2023 Tokenize Agreement”) with Magic and GBT Tokenize. The 2023 Tokenize Agreement restated and replaced the 2022 Tokenize Agreement. Pursuant to the 2023 Tokenize Agreement, as a result of the contribution of the Technology Portfolio by Tokenize and the subsequent contribution of services for the development of the Technology Portfolio by Tokenize and Magic, GBT Tokenize has been able to continue in operation, which has benefited the Company despite its contribution of 166 million shares of common stock valued at approximately $50,000. In order to maintain its 50% ownership interest in GBT Tokenize, the Company agreed to contribute its portfolio of intellectual property to GBT Tokenize and issue to GBT Tokenize <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20230719__20230720__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zgplFurSlPP" title="Number of shares converted">1,000 shares of Series I Preferred Stock (the “Series I Stock”) with a stated value of $<span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20230719__20230720__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zxRSUc5i7rV5" title="Debt conversion converted instrument, value">35,000 per share which is convertible into common stock of the Company by dividing the stated value by the conversion price of $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20230720__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zD4XzwDRevXc" title="Conversion price">0.0035, which, if converted in full would result in the issuance of 10 billion shares of common stock of the Company. Further, the Series I Stock will vote on an as converted basis. As of March 31, 2026 and December 31, 2025, there are 1,000 and 1,000 shares of Series I Preferred Shares outstanding, respectively. Treasury Shares On April 25, 2011, the Company issued a press release announcing that its Board of Directors approved a share repurchase program. Under the program, the Company is authorized to purchase up to 200-post-split (1,000,000 pre-split) of its shares of common stock in open market transactions at the discretion of management. All stock repurchases will be subject to the requirements of Rule 10b-18 under the Securities Exchange Act of 1934, as amended and other rules that govern such purchases. As of March 31, 2026 and December 31, 2025, the Company has 8 and 8 treasury stock on a cost basis of $11,059, respectively. As of March 31, 2026 and December 31, 2025, the Company has 1,032 and 1,032 shares to be cancelled on a cost basis of $632,000, respectively.

0.00001

1-for-500

30000000000

6559534118

555680

1880

3404641595

34046

2000000000

20000

22217870775

20217870775

45000

700

625000

20000

10000000

2021-12-31

20000

500

20000

1000

35000

0.0035

1000 1000 8 8

11059

1032 1032 632000 632000

Note 12 - Legal Proceedings From time to time, the Company may be involved in various litigation matters, which arise in the ordinary course of business. There is currently no litigation that management believes will have a material impact on the financial position of the Company.

Note 13 - Contingencies Potential IP’s Sale Effective as of March 20, 2024, Tokeniz, entered into a Patent Purchase Agreement with VisionWave Technologies Inc. (“VisionWave”) pursuant to which VisionWave agreed to acquire from Tokenize the entire right, title, and interest of certain patents and patent applications providing an intellectual property basis for a machine learning driven technology that controls radio wave transmissions, analyzes their reflections data, and constructs 2D/3D images of stationary and in motion objects (“VisionWave PPA”). The Purchase Price for the asset is $30,000,000 (the “Purchase Price”), which VisionWave will pay with shares of common stock, $0.0001 par value per share (the “Common Stock”). The Parties agree that the final Purchase Price may be adjusted and will be governed by a valuation report issued by a professional third party (“Valuation”). If the final Purchase Price per Valuation is less than $30,000,000, Tokenize has the option to cancel this Agreement. In accordance therewith, VisionWave agreed to issue and deliver to Tokenize, 1,000 shares of Common Stock (the “Shares”) representing 50% of VisionWave’s issued and outstanding shares of Common Stock, where the remainder of the 50% of VisionWave’s issued and outstanding shares of Common Stock are owned by a corporation controlled by Stanley Hills. Effective June 4, 2024 Tokenize been issued additional 222 shares from VisionWave for consideration of 10 million AVAI shares that been vested under VisionWave name. On March 26, 2024, Bannix Acquisition Corp., a Delaware corporation (“Bannix”), entered into a Business Combination Agreement (the “Original Agreement”), by and among Bannix, VisionWave Technologies, Inc., a Nevada corporation (“Target”) and the shareholders of Target. On September 6, 2024, Bannix entered into a Merger Agreement and Plan of Reorganization (the “Merger Agreement”), by and among Bannix, VisionWave Holdings, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Bannix (“VisionWave Holdings”), BNIX Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of VisionWave Holdings (“Parent Merger Sub”), BNIX VW Merger Sub, Inc., a Nevada corporation and direct, wholly owned subsidiary of VisionWave, and Target. The Merger Agreement and the transactions contemplated thereby were approved by the boards of directors of each of Bannix, VisionWave Holdings, Parent Merger Sub, Company Merger Sub, and Target. Said Merger was closed on July 14, 2025 and the Company holdings in Visionwave Technologies been converted into holdings in VisionWave Holdings, Inc publicly traded on NASDAQ under the Ticker VWAV. Here is the breakdown of the Company and Tokenize holdings in VisionWave Holdings post closings: <table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfShareholdersSharesIssuedAndOutstandingTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TokenizeHoldingsMember_zN8ys8O49Xb9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Contingencies (Details)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Shareholder’s Name</td><td> </td> <td colspan="3" style="text-align: center">No. Of Shares</td><td> </td> <td colspan="3" style="text-align: center">% of Shares Held</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">GBT Tokenize Corp.</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_ecustom--NumberOfBreakdownOfShares_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveOneMember__srt--CounterpartyNameAxis__custom--GBTTokenizeCorpMember_zWZwZKNa73Vk" style="width: 12%; text-align: right" title="Number of shares">897,102</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_ecustom--PercentageOfSharesHeld_dp_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveOneMember__srt--CounterpartyNameAxis__custom--GBTTokenizeCorpMember_zj6heimN7dti" title="Percentage of shares held">6.286</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">GBT Technologies, Inc.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--NumberOfBreakdownOfShares_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveOneMember__srt--CounterpartyNameAxis__custom--GBTTechnologiesIncMember_zIlAu4c1Xx32" style="text-align: right" title="Number of shares">2,020,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_ecustom--PercentageOfSharesHeld_dp_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveOneMember__srt--CounterpartyNameAxis__custom--GBTTechnologiesIncMember_zW9wCC4VfUc4" title="Percentage of shares held">14.158</td><td style="text-align: left">%</td></tr> </table>

30000000 30000000 <table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfShareholdersSharesIssuedAndOutstandingTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TokenizeHoldingsMember_zN8ys8O49Xb9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Contingencies (Details)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Shareholder’s Name</td><td> </td> <td colspan="3" style="text-align: center">No. Of Shares</td><td> </td> <td colspan="3" style="text-align: center">% of Shares Held</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">GBT Tokenize Corp.</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_ecustom--NumberOfBreakdownOfShares_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveOneMember__srt--CounterpartyNameAxis__custom--GBTTokenizeCorpMember_zWZwZKNa73Vk" style="width: 12%; text-align: right" title="Number of shares">897,102</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_ecustom--PercentageOfSharesHeld_dp_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveOneMember__srt--CounterpartyNameAxis__custom--GBTTokenizeCorpMember_zj6heimN7dti" title="Percentage of shares held">6.286</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">GBT Technologies, Inc.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--NumberOfBreakdownOfShares_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveOneMember__srt--CounterpartyNameAxis__custom--GBTTechnologiesIncMember_zIlAu4c1Xx32" style="text-align: right" title="Number of shares">2,020,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_ecustom--PercentageOfSharesHeld_dp_c20260101__20260331__srt--TitleOfIndividualAxis__custom--TokenizeholdingsinVisionWaveOneMember__srt--CounterpartyNameAxis__custom--GBTTechnologiesIncMember_zW9wCC4VfUc4" title="Percentage of shares held">14.158</td><td style="text-align: left">%</td></tr> </table> 897102 0.06286 2020500 0.14158

Note 14 – Concentrations Liquidity risk The Company has an accumulated deficit of $296,184,220 and has a working capital deficit of $10,585,707 as of March 31, 2026, which raises substantial doubt about its ability to continue as a going concern as the Company does not have sufficient funds to discharge its current liabilities.

Note 15 - Subsequent Events The Company has evaluated its operations subsequent to March 31, 2026 to the date these unaudited consolidated financial statements were available to be issued and determined the following subsequent events and transactions required disclosure in these consolidated financial statements.

During the quarter ended March 31, 2026, no director or officer adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) of Regulation S-K. true true true true